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Our thoughts and prayers are with our nursing community; particularly those who have 
lost loved ones. The year 2020 is the International year of the nurse and it is heartening 
to see the footage of people around the world clapping, cheering and showing gratitude 
for our nurses and healthcare workers.  
 
The world has never been so dependent on the resilience of nurses.  We have an 
innate ability to deal with uncertainties and brace for shifts of unknown clinical 
challenges. Despite what is thrown at us we turn around and return the next day or 
night and do it all again.  We are human, we are fearful and anxious, we do cry and 
weep but we are made stronger by our conviction to provide care with compassion.  
 
The world acknowledges that nurses are the mainstay of this battle against Covid-19, 
and recognition is so important during this pandemic. Please keep safe, stay strong, 
take care of yourself as well as others and we will look back on this knowing that the 
world did recognise our courage and dedication to those that need our care.              
   
  Linda 
 
DOI: 10.21307/ajon-2020-000a 
2020Thoughts from the Editor and ANNA Executive 
 
Linda Nichols 
University of Tasmania, AJON Editor 
2020 The Year of the Nurse 
 
Caroline Woon 
Nurse Educator, Neurosciences, Capital & Costal District Health Board New Zealand 
Celebrating Florence Nightingale, the pioneer of nursing, 
2020 the year of the nurse, absolutely deserving. 
 
Covid 19 has taken the world by storm, 
Life changed so much from what was known as the norm! 
 
All around the world people are stressed and hurting, 
Loss of jobs, loss of life, all quite disconcerting. 
 
We are united worldwide as nurses in this crisis, 
Demonstrating our resillience, adaptability and kindness. 
 
Discussions and anxieties over personal protective equipment,  
The world is acknowledging hospital staff for their commitment! 
 
Neuroscience nurses, across Australasia, in this together 
Flattening the curve, preventing the spread now or never! 
 
We have always worked hard and put our patients first, 
Sacrificed our safety and time to ensure patients are nursed! 
 
But now is the time to care for ourselves and ensure we get rest, 
So we can care for our patients and give them our very best. 
 
DOI: 10.21307/ajon-2020-000b 
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Pandemics and the neurological 
manifestations of viral respiratory 
illnesses including Covid-19.  
 
Editor: Linda Nichols 
  
Christie, Vicki and Dawn raise some really 
valid and pertinent thoughts and as I reflect 
on their guest editorial in our current Global 
crisis, the nexus between my two own areas 
of specialty becomes increasingly pellucid. 
After leaving clinical neuroscience practice 
for academia, immunisation and public health 
intervention is the mainstay of my clinical 
practice.  Preventative health care measures 
have never been so imperative. From hand 
hygiene, cough etiquette and the elusive 
Covid-19 (SARS-CoV2) vaccine we are ex-
posed to unparalleled and extraordinary me-
dia and social media coverage (Khan, Ali, 
Siddique, & Nabi, 2020). The current Covid-
19 health crisis is stretching our health re-
sources, nurses and medical staff to their 
absolute limits. Until recently it has been neu-
rotropic viruses such as the measles virus 
that have generally been associated with 
central nervous system pathologies. Howev-
er respiratory viruses including influenza and 
coronaviruses are emerging with neuropatho-
logical elements (Bohmwald, Gálvez, Ríos, & 
Kalergis, 2018). So what do we know about 
the history and impact of pandemics and how 
do novel respiratory viruses relate to neuro-
science? 
 
Viral respiratory illnesses and pandemics 
have been described since as early as 
412BC. We are all familiar with the 1918 
H1N1 (Spanish flu) influenza pandemic, but 
we often forget about the 1957 H2N2 (Asian 
flu) or the 1968 H3N2 (Hong Kong flu) influ-
enza pandemics that both resulted in millions 
of lives lost.  Our next influenza pandemic did 
not occur for another 51 years and caught 
many unaware. In early March 2009 cases of 
a novel H1N1 influenza strain (that is be-
lieved to have originated from pigs) emerged 
in California and Mexico (Broadbent & Sub-
barao, 2011). By May 2009 the first cases of 
the colloquially named “swine flu” were diag-
nosed in Australia (Australian Government 
Department of Health and Ageing, 2009; 
Eastwood, Durrheim, Jones, & Butler, 2010). 
Those like myself that were working during 
this time will remember being individually 
fitted for P3 masks and getting a sticker ones 
name badge that indicated size and fit, with  
shelves filled with different shapes and sizes 
of masks. This is such a contrast to this pan-
demic, where mask shortages and equip-
ment deprivations are being reported interna-
tionally. The H1N1/09 pandemic is described 
by some as being relatively benign 
(Kotsimbos et al., 2010). This in part is due to 
the launch of the H1N1 vaccination program 
using the Panvax® vaccine that became 
available a mere 6 months after the virus was 
first identified (Bishop, Murnane, & Owen, 
2009; Eastwood et al., 2010). However, vac-
cination is not an easy fix and various itera-
tions of the (H1N1)pdm09-like virus strain 
have been included internationally in the sea-
sonal flu vaccinations since 2010 to keep the 
spread in check. No pandemic is the same 
and each presents unique challenges for 
Governments, health care services and the 
community (Kotsimbos et al., 2010). We are 
only at the beginning of this current Covid-19 
journey and still in a phase where we are 
working to contain and sustain our resources. 
Protection through a potential vaccine is still 
a long way off and likely to take years before 
control is effective. 
 
Like influenza, coronaviruses are a group of 
related viruses that are zoonotic and primari-
ly cause respiratory symptoms in humans 
(Chen et al., 2020; Su et al., 2016). Unlike 
influenza, there are no antiviral drugs or vac-
cines to treat or prevent human coronavirus 
infections. Coronaviruses are relatively new, 
having been first discovered in animals in the 
1930’s, with the common cold the first human 
coronavirus discovered in the 1960’s 
(Kirkpatrick, 1996; Su et al., 2016).  Covid-19 
Pandemics and the neurological manifestations of viral 
respiratory illnesses including Covid-19.  
 
Editor: Linda Nichols 
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is the third serious coronavirus outbreak to 
occur in the last 20 years, following the 2003 
severe acute respiratory syndrome (SARS) 
and 2012 Middle East respiratory syndrome 
(MERS) outbreaks (LeDuc & Barry, 2004; 
Yang et al., 2020).  Influenza and corona-
viruses share many similarities, including the 
manifestation of neurological symptoms as-
sociated with poor outcomes (Li, Bai, & 
Hashikawa, 2020; Mao et al., 2020; Talan, 
2020). It is not clear whether these symp-
toms and subsequent neurological events 
are a direct cause of the virus entering the 
central nervous system, or an indirect re-
sponse to an overwhelming systemic viral 
storm (Fitzgerald, 2020). The most likely 
mode of infection is either a haematogenous 
or retrograde neuronal route (Mao et al., 
2020).  
 
Around 73% of Covid-19 cases are reported 
as being mild, however for the 18% of indi-
viduals who present with severe symptoms 
(Tian et al., 2020), the likelihood of neurologi-
cal symptoms and complications increases.  
Mao et al. (2020) were among the first to re-
port the prevalence of neurological symp-
toms associated with Covid-19, with 36% of 
individuals within their hospital-based cohort 
experiencing neurological symptoms. Clinical 
neurological manifestations include mild 
symptoms such as headache, dizziness and 
ataxia, myalgia (Lai, Shih, Ko, Tang, & 
Hsueh, 2020; Li et al., 2020; Mao et al., 
2020; Talan, 2020), as well as more signifi-
cant subsequent neurological events includ-
ing altered level of consciousness, stroke, 
seizures, encephalopathy and central respir-
atory failure (Chen et al., 2020; Mao et al., 
2020). Post-viral immune mediated complica-
tions such as acute disseminated encephalo-
myelitis and Guillain-Barré syndrome are al-
so reported (Talan, 2020). Hypoxic encepha-
lopathy associated with viral infections is of-
ten intractable and associated with an acute 
and rapid neurological deterioration 
(Achiriloaie et al., 2016). The spread of virus-
es via a synapse-connected route to the 
brainstem, including the medullary cardi-
orespiratory centre, is potentially partially 
responsible for acute respiratory failure 
(Khan et al., 2020; Li et al., 2020; Matsuda et 
al., 2004).  Rates of hypoxic encephalopathy, 
as high as 20% in hospitalised cohorts (Chen 
et al., 2020), are also similar to previous in-
fluenza studies (Newland et al., 2007). 
We are only just beginning to learn about 
Covid-19’s various manifestations and com-
plications. Whilst it is too early to make defi-
nite statements, the neuroinvasive propensity 
of Covid-19 has been well documented and 
not unexpected from our knowledge of influ-
enza and other coronaviruses. Defined as 
“the greatest medical holocaust in histo-
ry” (Waring, 1964), the 1918 pandemic of 
Spanish flu may yet be surpassed. Covid-19 
has resulted in a worst-case scenario where 
lives are dominated by not only loss but also 
by unimaginable social and economic priva-
tion. So, now is the time to advance our 
awareness and to share our nursing 
knowledge with each other. We are already 
seeing that Covid-19 does not limit infection 
to the cardiorespiratory system. While the 
overall mortality of Covid-19 is lower than 
that of both SARS and MERS, its atypical 
symptoms, rapid person to person transmis-
sion and international spread is making it 
more deadly (Chen et al., 2020). It will be our 
awareness and close attention to neurologi-
cal manifestations that will enable swift inter-
vention and the possible saving of lives.   
  
Linda 
 
Linda Nichols 
Editor 
 
DOI: 10.21307/ajon-2020-001a 
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As mortality rates decline, the global burden 
of neurological disease is on the rise. Stroke 
affects 15 million people worldwide each 
year, contributing to 5 million deaths and an-
other 5 million left with permanent disability 
(Vos et al., 2017).  By 2050, the rate of de-
mentia is expected to triple to 115 million 
worldwide (Prince et al ., 2013). Over the last 
twenty years, we have seen dramatic ad-
vances in the treatment of neurological dis-
ease.  The National Institute of Neurological 
Disease (NINDs) trial that tested t-PA 
opened the door for successful treatment of 
acute stroke reducing death and disability 
(Koroshtez, 1996). In 2015, the results of five 
trials that evaluated endovascular treatments 
showed the profound benefit of early removal 
of thrombus in anterior circulation strokes 
(Goyal et al., 2016). Lessons from Finland 
taught us to reorganize our care, bypassing 
the red tape of  “checking in patients” to 
adopt a “door to CT” approach that substan-
tially reduced “door to needle” times and im-
proved outcome (Lindsberg et al., 2006). In 
developed countries, medical progress has 
promoted the growth of specialized care units 
and tailored treatment for stroke, traumatic 
brain injury, dementia and Parkinson’s dis-
ease.  These advances have opened the 
door for dedicated nursing training with certi-
fication programs like the Neuro Criticalcare 
Society’s Emergency Neuro Life Support 
(ENLS) aimed at improving care in the first 
critical hour after any neurological emergen-
cy. However, all of these advances come at a 
cost. 
 
As the care of neurological disease becomes 
more sophisticated, the countries that are 
least able to afford the equipment or mobilize 
highly subspecialized teams will experience a 
widening gap (Carroll, 2017). Treatment that 
relies on extensive resources may be imprac-
tical when it is accomplished at the expense 
of other critical services. It’s impossible to 
consider an endovascular approach to stroke 
care when two patients are sharing a bed 
and generator power is at best, intermittent. 
The challenge is to surround these countries 
with range of solutions to provide best care 
within their existing resources.  
 
A thoughtful evaluation that assumes nothing 
is essential. In some countries, nurses still do 
not perform a neurological exam. This level 
of evaluation still resides at the physician 
level. Changing patterns of care is highly po-
litical and requires an advanced working 
knowledge of education standards, workforce 
utilization and the available support for 
change. The acceptance and willingness to 
change from the inside and to see things in a 
different way is required. “Outsiders” cannot 
push something that is not supported from 
within. For example, if a nurse is responsible 
for the care of 45 patients, the overwhelming 
burden of basic care tasks may exclude more 
advanced neurological evaluation. The physi-
cal challenges of available supplies may also 
be a barrier.  They may lack the funds to pur-
chase or maintain neuromonitoring equip-
ment or have access to the qualified staff 
needed to insert such devices. Local roles 
and responsibilities may differ substantially 
and education programs must be carefully 
crafted with the patient as the central focus.  
 
The World Federation of Neuroscience Nurs-
es (WFNN) represents more than 8,800 
members world-wide with representation 
from 13 countries. Initiatives over the last 
decade have been aimed at connecting nurs-
es globally to promote the professional prac-
tice of neuroscience nursing, foster an open 
dialogue about the care of neurological dis-
ease that crosses cultures and national 
boundaries and support the development of 
professional neuroscience nursing societies. 
WFNN education projects have been con-
centrated on basic skills like the neurological 
examination that is the cornerstones of pa-
tient management. In partnership with the 
member nations, it is the Quadrennial Con-
gress that connects nurses from across the 
world to share nursing research, expand the 
fund of knowledge and forge international 
friendships that raise the standard of care 
worldwide.  
 
A Neuro Reflection 
 
WFNN Executive:  Christi DeLemos, Vicki Evans & Dawn Tymianski . 
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As the global burden of neurological disease 
rises, we must leverage professional partner-
ships to improve regional education. The 
Australasian Neuroscience Nurses Associa-
tion and other WFNN members must work 
together to meet the growing challenge by 
improving access to basic neuroscience 
nursing training. Public education focused on 
prevention, is equally important. Key partners 
working in tandem with this effort include the 
European Association of Neuroscience Nurs-
es (EANN), Neurocritical Care Society, 
(NCS), World Federation of Neurological So-
cieties (WFNS), The World Stroke Organiza-
tion (WSO), the Movement Disorders Society 
(MDS), the World Parkinson’s Association 
(WPA), The International League Against 
Epilepsy, (ILAE), The Multiple Sclerosis Inter-
national Federation (MSIF) the World Feder-
ation of Neurorehabilitation (WFNR) and nu-
merous others.  
 
In 2021, the WFNN will welcome nurses from 
across the world to join us in Darwin, Austral-
ia for the 13th Quadrennial Congress. The 
Congress represents a unique opportunity to 
learn from one another and advance global 
bank of knowledge. Share your nursing 
knowledge with the world! More information 
is available on the website at www.wfnn.org  
As a benefit of membership in ANNA, your 
membership with the WFNN is already paid. 
If you have developed leadership skills and 
you are looking for a global challenge, WFNN 
is accepting applications for leadership posi-
tions. Information can be found at https://
wfnn.org/about.  
 
We look forward to meeting you in  
Darwin! 
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Introduction 
Oral care is a pertinent issue in neurosci-
ence nursing as many patients are unable 
to maintain their oral hygiene due to re-
duced consciousness, cranial nerve palsies 
or limb weakness.  Oral care practice is 
based on tradition or experience rather than 
evidence based (Cohn &Fulton, 2006; 
Coker et al., 2017).  Thirteen studies on oral 
hygiene practice and experience in nursing 
were explored.  Binkley et al (2004) devel-
oped a questionnaire tool which formed the 
basis of four surveys (Chan & Ng., 2012; 
Perrie & Scribante., 2011; Saddki et al., 
2014; Soh et al., 2011).   
 
Binkley et al. (2004) carried out a large 
quantitative survey (n = 556) which had face 
and content validity, was developed by a 
research team and conducted in 421 inten-
sive care units in the United States.  
 
 
 
 
Aims: To understand the experience and knowledge of neuroscience nurses working in acute 
ward settings in New Zealand regarding oral care. 
To determine what educational requirements were needed to standardise oral care.   
 
Data sources: A systematic review of articles was conducted using Cinahl, PubMed, Cochrane 
and Google scholar between 2007-2019.   
 
Methods: An online survey using Survey Monkey with three out of five units participating from the 
north and South Island of New Zealand using qualitative and quantitative data.  
 
Results: 34% of nurses completed the survey from three different neuroscience wards.  Oral hy-
giene education was provided to the majority of respondents during their initial nursing training, 
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standardization of care across all neuroscience wards.   
 
Keywords:  
 
Oral care, neuroscience, nursing guidelines, assessment tools  
Oral Care for Neuroscience patients in New Zealand – A 
national survey  
 
Caroline Woon 
Nurse Educator, Neurosciences, Capital & Costal District Health Board New Zealand 
Questions or comments about this article should be   
directed to  Caroline Woon 
Email address: Caroline.Woon@ccdhb.org.nz 
 
DOI: 10.21307/ajon-2020-002 
Copyright © 2020ANNA 
Australasian Journal of Neuroscience  Volume 30 ● Number 1 ● May 2020 
 11 
Twenty-seven questions using the five-point 
likert scale examined attitudes, knowledge 
and belief, types and frequency of care pro-
vided, training and hospital provision within 
their questionnaire.   
Three studies of neuroscience nurses were 
identified, from the Netherlands, USA and 
the United Kingdom (Cohn & Fulton, 2006; 
Hollaar et al., 2015; Horne et al., 2015).  
The USA study was small, for both nursing 
staff (38%, n=15) and unlicensed staff or 
health-care assistants (60%, n=15) (Cohn & 
Fulton, 2006).  This was the only study to 
question health-care assistants as well as 
nursing staff.  They used different question-
naires for the two groups and looked at atti-
tudes, beliefs and preferences regarding 
oral care.  This study recommended the use 
of open-ended questions to collect more 
information.  Hollaar et al. (2015) used a 
questionnaire to examine the knowledge 
and skills of nursing staff in oral hygiene, 
and also educated staff using a guideline 
and then evaluated their knowledge by ex-
amination (n = 18).  Both the above studies 
were small, carried out in a single hospital, 
so generalizability was limited.  Horne et al. 
(2015), carried out a mixed-method survey 
using a combination of focus groups and 
telephone interviews with senior nurses on 
a stroke unit (n = 11). Common themes 
arose including oral care was a neglected 
area, stroke patients lacked awareness of 
the importance of oral hygiene and there 
was a lack of advice provided for them.  
Nurses were aware of the importance of 
effective oral care but lacked knowledge 
and education. Protocols and assessment 
tools were also unavailable. 
There were no studies exploring oral care 
amongst neuroscience nurses in Australa-
sia.  Only three studies worldwide explored 
neuroscience nurses’ experiences and prac-
tice in oral care and most were conducted in 
intensive care. Therefore, a need existed to 
explore ward nurses’ experience and prac-
tice in oral care.  Several common findings 
of the surveys regarding oral hygiene prac-
tice and experience in nursing existed which 
will be discussed.   
THE STUDY 
Methods: 
Research aim 
This study aimed to explore the experience 
and knowledge of nurses, working on acute 
neuroscience wards providing oral care for 
their patients.  The findings will aim to con-
tribute to the development of evidence 
based oral hygiene education to guide and 
standardize practice in New Zealand.    
Survey design  
This survey was designed as a cross sec-
tional survey.  Binkley et al (2004) permitted 
the use of their validated questionnaire and 
the original was provided.    Some state-
ments and questions were changed to re-
flect experiences of ward nurses providing 
oral care rather than critical care units and 
the language was also reviewed.   
The survey was designed online using Sur-
vey Monkey with twenty five questions.  
Closed questions were used to reduce the 
time for completion; some contained the 
option ‘other’ so participants could make 
additional comments.  A series of state-
ments using the 5 point Likert scale were 
modified and included to reflect the ward 
setting.  (See appendix 1).   
The quantitative questions collected nomi-
nal and ordinal data.  Qualitative questions 
were explored to gain more knowledge and 
scenario-based questions included as it was 
more realistic, allowed for deeper insight, 
and was suggested in a previous study 
(Chan & Ng, 2012).  Content validity was 
ensured by consultation with a hospital den-
tist who reviewed the questionnaire.  A fo-
cus group of five local neuroscience ward 
based nurses pre-tested the questionnaire.   
Telephone interviews were conducted with 
the educators or nurse managers who acted 
as gatekeepers to determine their oral care 
practice within their ward.   
Sample  
There were approximately 150 neurosci-
ence nurses within five neuroscience wards 
in five hospitals in New Zealand.  To maxim-
ize sample size and increase external validi-
ty, purposive sampling was used, targeting 
a group of people with specific characteris-
tics or experiences.  In this survey, one unit 
declined participation and the researchers 
own ward was excluded. Therefore three 
neuroscience wards in three tertiary hospi-
tals in New Zealand participated.  The inclu-
sion criteria comprised neuroscience regis-
tered nurses and enrolled nurses working 
clinically on an acute ward. Nurses working 
in all ethnic groups, ages, levels of experi-
ence and genders were included. .  The ex-
clusion criteria included any health care pro-
fessionals who were not nurses, any nurses 
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working in critical care or nurses who were 
not working clinically.   
Data collection 
Questionnaires were distributed via email to 
the gatekeepers who were nurse educators 
or ward managers to all three units using 
Survey Monkey.  A reminder email was sent 
once a week for four weeks to ensure a 
maximum sample size.   After 4 weeks, 
there were only 22 responses, so the survey 
period was extended by three weeks for a 
total of 7 weeks.  This produced 34 re-
sponses.   
Ethical considerations 
The ethics application for this study was 
reviewed by a committee of experienced 
academic researchers and was judged to be 
low risk.  The Massey University Code of 
Ethical Conduct, Teaching and Evaluations 
involving Human Subjects (2015) guided the 
research process.  
Demographics   N = 34 % 
Category of nurse An enrolled nurse 2 5.9% 
A Registered nurse 32 94.1% 
Gender Male 3 8.8% 
Female 31 91.2% 
Highest level of 
professional qualification 
Nursing diploma 4 11.8% 
Bachelor of Nursing 13 38.2% 
Post graduate certificate 9 26.5% 
Post graduate diploma 4 11.8% 
Post graduate masters 3 8.8% 
Other (please specify) 1 2.9% 
Years of nursing experience <1 yr 1 2.9% 
1-10 yrs 18 52.9% 
11-20 yrs 6 17.6% 
21-30 yrs 6 17.6% 
31-40 yrs 1 2.9% 
41-50 yrs 2 5.9% 
Range 0.5-45 yrs     
Mean 12 yrs   
Country of nursing training New Zealand 26 76.5% 
Philippines 4 11.8% 
United Kingdom 2 5.8% 
Other 2 5.8% 
Table 1. Demographic Profile of Participants 
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Participants had the right to full disclosure of 
information.  An information sheet was sent 
with the questionnaire to explain the ra-
tionale and ensure participants were fully 
informed about the research.  Consent was 
implied when they chose to complete the 
survey.   The information was kept securely 
in a password protected computer and the 
data was securely archived.  The institutions 
and clinical leaders gave their consent for 
the research to be conducted and their re-
search departments were fully informed.   
Data analysis 
The quantitative data was exported from 
Survey Monkey into an excel spreadsheet, 
further exported into the Statistical Package 
for Social Sciences (SPSS) and screened 
for incomplete information.  Descriptive sta-
tistics and frequencies were used to analyze 
the results.  This data was presented in ta-
bles and graphs.  A content analysis was 
used to analyze the qualitative data from the 
questionnaire. In this study, the data from 
the open-ended questions were read and 
put into categories identifying key themes 
and then collated in a table with examples 
of common responses.  
Results and discussion: 
Demographics 
There were 94.1% (n=32) registered nurses, 
5.9% (n=2) enrolled nurses in the sample 
and of these 91.2% (n=31) were female 
(Table 1).  Some nurses had nursing experi-
ence over 40 years 5.9% (n=2) but the ma-
jority worked between 1-10 years (52.9 %, 
n=18).  The mean nursing experience was 
12 years.    
Oral hygiene education and knowledge per-
ception 
The majority of these nurses (64.7%, n=22) 
recalled having oral hygiene education dur-
ing their nursing training.  Adequate training 
was reported by 55.9–88% of nurses in oth-
er studies (Binkley et al., 2004; Chan & 
Ng.,2012; Saddki et al., 2014; Soh et al., 
2011).  Some of these nurses believed their 
education was adequate (40.6%. n=13) with 
25% (n=8) rating their oral hygiene training 
as inadequate.  When starting on their cur-
rent ward, 57.6% (n=19) of the nurses did 
not receive any oral hygiene education. A 
total of, 60.6% (n=20) of the nurses believed 
their oral hygiene knowledge was good. 
With 65–94.7% of nurses were keen for fur-
ther training or guidelines. 
Statements about oral hygiene: 
Attitudes 
Nurses were asked to comment on a series 
of statements using a 5 point Likert scale of 
strongly disagree, disagree, neutral, agree, 
and strongly agree.  The majority of re-
spondents agreed that oral hygiene was a 
high priority when caring for their patients 
(agreed 50%, n=17; strongly agreed 35.3%, 
n=12).  This is comparable to the literature 
where over 89% of the nurses rated oral 
hygiene a high priority (Azodo et al., 2013; 
Binkley et al., 2004; Chan & Ng, 2012; Per-
rie & Scribante, 2011; Saddki et al., 2014; 
Soh et al., 2011).    Almost all nurses be-
lieved that oral care significantly impacted 
on their patients’ clinical outcomes with 
52.9% (n=18) agreeing and 26.5% (n=9) 
strongly agreeing.  Most nurses were also 
satisfied with their own oral care provided to 
patients with 44.1% (n=15) agreeing and 
26.5% (n=9) strongly agreeing.  Although 
some nurses believed other procedures 
took priority over oral care (47.1%, n=16).    
Professional development 
Nurses were asked to comment on several 
statements regarding oral hygiene educa-
tion and educational requirements.  The 
majority of respondents remained neutral on 
whether they required more information on 
evidence based oral care (41.2%, n=14) or 
an in-service session (47.1%, n=16) with a 
mode of 3 for each statement. In the survey, 
85% (n=29) of the respondents did not have 
an oral assessment tool available for use on 
the ward.  Some respondents agreed 
(47.1%, n=14), and 14.7% (n=9) strongly 
agreed that they assessed the oral health of 
their patients regularly, although 42.4% 
(n=13) agreed and 27.3% (n=8) strongly 
agreed they would like an oral assessment 
tool to help them assess the oral health of 
their patients.   
Management of oral care  
Nearly half of the respondents said nurses 
were solely responsible for the oral care of 
patients (47%, n=16) although others 32% 
(n= 11) thought that nurses and health care 
assistants shared responsibility.  With a lack 
of training and inability to use suction it 
would be inappropriate to delegate this task 
to a health care assistant, as it is beyond 
their scope of practice (Klein et al., 2017).  
Health-care assistants should be educated 
about the principles of oral care but, only 
nurses should provide oral care for patients 
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with dysphagia.  Neuroscience patients are 
a complex population with aphasia or dys-
phagia, an impaired ability to chew with re-
duced oral clearance increasing bacterial 
load and high risk of pneumonia and there-
fore should be cared for by nurses due to 
aspiration risk (Ajwani et al, 2017; Kwok et 
al 2015).  
 Dental teams and complications    
The majority of nurses were unsure if a den-
tal team was available in the hospital 
(55.88% n=19).  Nurses were asked to com-
ment on when they would contact the dental 
team and three people mentioned for infec-
tions and two specified brain abscesses.  
Some mentioned broken, loose or rotten 
teeth.   In a study of nurses and health-care 
assistants, Cohn and Fulton (2006) deter-
mined that 60% were aware of a lack of ex-
pert input, particularly surrounding guide-
lines, and recommended that such input is 
important to improve care. A qualitative 
question was asked about the complications 
caused by poor oral hygiene to assess nurs-
es’ knowledge.  Infection, although unspeci-
fied, was frequently mentioned (n=17) as 
well as thrush (n=16).  Dry mouth, halitosis 
(bad breath) was mentioned infrequently.  
Poor oral hygiene leads to pneumonia, pro-
longed hospital stay and even death 
(Dietrich et al, 2017; Martino, 2005; Scanna-
pieco & Shay 2014).  There was no mention 
by respondents of a link with cardiovascular 
disease, stroke and a poorer prognosis of 
diabetes, as identified in the literature 
(Borgnakke et al., 2013; Dietrich et al, 
2013).   
Barriers 
A lack of co-operation was the biggest barri-
er to effective oral care in this study (see 
graph), with issues related to low levels of 
consciousness, lack of bite reflex and confu-
sion identified. These conditions were also 
identified in other studies (Costello & 
Coyne, 2008; Hollaar et al., 2015; Chan & 
Ng, 2012).  Nurses lacked the ability to ac-
cess the mouth as patients often bite down, 
which was the second most common barrier 
reported.  Dale et al. (2016) carried out an 
ethnographic study of intensive-care nurses 
and their experiences of oral care and de-
termined that it is difficult to provide oral 
care when the patients bite down, making 
access difficult.  Bite blocks or tools to open 
the mouth need to be explored.  The third 
most common barrier was unstable or criti-
cally unwell patients also identified as a bar-
rier by Chan and Ng (2012).   
Time was a common barrier and could be 
related to the nurse–patient ratio, which is 1 
nurse to 4–6 patients in neuroscience wards 
in New Zealand, compared to 1 nurse to 1–
2 patients in critical care, as in the study by 
Chan and Ng (2012).  Costello and Coyne 
(2008), in their survey of nurses in the Unit-
ed Kingdom, also reported time as a com-
mon barrier.  This could be linked with inad-
equate staffing, which is widely reported in 
nursing (Twigg et al., 2015).  Improved 
nurse–patient ratios contribute to improved 
outcomes (Aiken et al., 2011). When con-
sidering time as a factor, most respondents 
said that oral care would take between 5 
and 10 minutes.  The literature reported that 
a lack of time restricted the provision of ef-
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fective oral care (Wårdh, Hallberg, Berg-
gren, Andersson, & Sörensen, 2003; Costel-
lo & Coyne, 2008).  When recommending 
products, time must be a consideration and 
ease of product use is fundamental.   
Education of staff 
Professional development regarding oral 
hygiene emerged as an important issue 
from the results of the questionnaire.  Sev-
eral studies have identified that oral hygiene 
education is lacking and created a barrier to 
effective oral care (Costello & Coyne, 2008; 
McGuire, 2003; Smith et al., 2016; Talbot et 
al., 2005).   
Knowledge and products 
To assess the nurse’s knowledge a series 
of scenarios were given to determine their 
choice of products and frequency of use.  
There were differences in timing for the use 
of products and this is well reported in the 
literature (Costello & Coyne, 2008; Horne et 
al., 2014).  Oral care varies amongst nurses 
due to the large product range which is rare-
ly evidence based (Cohn &Fulton, 2006; 
Coker et al., 2017). However toothbrushes 
and paste were commonly used throughout 
the scenarios, which is recommended twice 
daily and prevents plaque build-up, perio-
dontitis and gingivitis (Chan & Ng, 2012; 
New Zealand Dental Association, 2010; 
Prendergast, Jakobsson, Renvert, & Hall-
berg, 2012; Prendergast et al., 2013).   
Mouthwash featured highly in all three sce-
narios; 79.41% of respondents used this 
product for mouth care; although this is 
known to cause xerostomia (dry mouth) and 
should be avoided (Eilers, 2004; Shi et al., 
2013).  Foam swabs were also reported to 
be commonly used for mouth care 
(79.41%).  Dale et al (2016) carried out an 
ethnographic study and reported the texture 
of these swabs are not popular and make 
oral care more difficult.  Swabs are predomi-
nantly for comfort care and do not replace 
toothbrushes and are not effective for the 
removal of plaque or debris (Chan & Ng, 
2012).   In the UK mouth swabs have been 
removed from practice due to a patient 
death (Medicines and Healthcare Product 
Agency, 2012).   
Nurses were asked if they would allow fami-
ly members to carry out oral care of a pa-
tient with a poor swallow and inability to pro-
vide their own care.  Surprisingly 48.48% 
(n=16) said they would allow them to pro-
vide care.  Family members should not car-
ry out this task for patients with poor swal-
low or cognition due to the risk of aspiration 
and pneumonia.  Garrouste-Orgeas et al. 
(2010), carried out a study to investigate 
family participation in the intensive care unit 
and 97% (n=101) of families wanted to be 
involved in care.  Oral care was thought to 
be one of the more appropriate tasks for 
families to provide by doctors, nurses and 
health care assistants.  However, while 
65.3% of nurses favoured family participa-
tion in oral care, some expressed concerns 
of adverse events during care.      
In the second scenario a patient had a dry 
mouth and lips, and was unable to provide 
their own care, a common situation in neu-
roscience patients.  Toothpaste and tooth-
brushes were used mostly 12 hourly.  
Mouthwash and swabs featured again in 
this scenario and, therefore, would add to 
the problem of dry mouth.  Artificial saliva 
was used by a third of the respondents for 
dry mouth, but this can cause a coating to 
form on the tongue and patients find this 
unpleasant or perceive more difficulty with 
swallowing as a result (Furness et al., 
2011).  A dry-mouth toothpaste and gel, 
such as the Oral7® product neutralizes the 
mouth and prevents the build-up of plaque, 
which was considered locally and recom-
mended by dentists. The gel acts as saliva 
in the mouth and can be used regularly with 
patients’ mouths easier to clean as a result.   
A patient with a full set of dentures was 
mentioned in the last questionnaire scenar-
io.  One-third of the respondents mentioned 
the use of denture tablets once daily. This 
should occur at night time, when dentures 
are removed for soaking in a sealed con-
tainer to prevent the occurrence of denture 
stomatitis and reduce the risk of pneumonia 
(Coker et al., 2017; Iinuma et al., 2015; 
Gendreau and Loewy, 2011).  Coker et al. 
(2017) reported that patients refuse to have 
their dentures removed while in hospital 
mostly because they don’t want to be seen 
without them, and they did not find that 
these patients developed denture stomatitis.  
However, wearing dentures overnight dou-
bles the risk of pneumonia according to Iinu-
ma et al. (2015).    
Availability of products was addressed by 
the questionnaire.  Toothbrushes, tooth-
paste, foam swabs, mouthwash and artificial 
saliva were provided in all of the three hos-
pitals.  However, the availability of denture-
cleaning tablets was low and needed to be 
addressed. 
Thrush was the most commonly mentioned 
complication nurses encountered in prac-
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tice, present in immunocompromised hospi-
talized patients, those with dysphagia, pa-
tients taking steroids or antibiotics, or pa-
tients with xerostomia (Kragelund et al., 
2016).  When asked about the oral compli-
cations that can occur in their patients, re-
spondents commented about dry mouth and 
a dry or coated tongue.  It is unclear wheth-
er this is attributed to the use of saliva sub-
stitutes.  
Guidelines and tools 
One hospital used a universal guideline, not 
specific to their department or neurosci-
ence, but the other two units did not.  In the 
survey, most nurses agreed that they would 
like to have an oral assessment tool.  No 
national guidelines were available to stand-
ardize care and thus variations occurred in 
oral care.   Currently, oral assessment tools 
exist for oncology and neuroscience inten-
sive care, but none are available for use 
with ward-based neuroscience patients 
(Eilers et al., 1988; Prendegast et al., 2013).  
There is also a lack of guidelines for oral 
care in neuroscience patients and there is a 
need for more research in this area (Hollaar 
et al., 2015).  A nationally available assess-
ment tool and guideline would be beneficial.   
Quality of results and limitations 
Generalizability was not possible, due to the 
small sample size (34%) The recruitment 
period had to be extended due to the poor 
uptake of the questionnaire from 4 weeks to 
7 weeks.  Bias has to be considered, as 
those nurses more interested in oral hy-
giene would have been more likely to partic-
ipate.  The individual wards were not identi-
fiable.  
Conclusion:  
This research was the first oral care survey 
of neuroscience nurses in New Zealand.  It 
was important to determine the knowledge 
and experience of these nurses to discover 
what was lacking and what was required to 
improve care.  Although the sample size 
was small, it was still possible to demon-
strate a variety of practices and knowledge 
along with a lack of guidelines or oral as-
sessment tools in use and therefore a lack 
of consistency in practice.  Nurses reported 
that oral care was a high priority.  Adequate 
education had been provided in nursing 
training, however there was a lack of oral 
hygiene continuing education on the ward.  
Nurses are pivotal in their provision of oral 
care and education is fundamental to en-
sure they understand their role and the im-
plications of ineffective oral hygiene.  Health 
care assistants also provide oral care but 
require further education.  Nurses should be 
responsible for the oral care of patients with 
dysphagia to prevent complications.   Col-
laboration between dentists, and nurses 
could be improved allowing improved refer-
ral processes.    
Mouthwash featured in the scenario re-
sponses and respondents appeared una-
ware of the consequence of xerostomia.  
Furthermore, oral swabs are a health and 
safety concern and should be removed from 
practice and replaced with a toothbrush for 
all oral care.  Further education is required 
for xerostomia.  A lack of denture paste and 
denture tablets existed in the ward environ-
ment and was highlighted nationwide with a 
range of products for implementation. Infec-
tion and thrush were the most reported 
complications, and education could be pro-
vided about the best care for these compli-
cations.   
Recommendations 
The development of an easy to use and 
quick to complete oral assessment tool and 
guideline would standardize care.  The main 
oral health problems are dry mouth, poor 
swallow, and dentures. The guideline needs 
to identify products useful for these condi-
tions.   Education should be provided regu-
larly for all nurses and health care assis-
tants in how best to provide oral care. 
Since the completion of this study, the oral 
care online learning package has been de-
veloped for use for health care assistants, 
nurses and speech and language thera-
pists.  A guideline (see appendix 1) and 
flowchart has been implemented with a pos-
itive response.  A standardized approach 
should be used to improve care with collab-
oration between hospitals.   
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Information sheet 
 
Neuroscience nurses knowledge and experience of oral hygiene in acute care.   
 
A questionnaire for nurses working in acute neuroscience areas 
 
You are invited to participate in a study about nurses knowledge and experience of oral hygiene in acute neurosciences.  
This project is being carried out by Mrs Caroline Woon who is a masters student at Massey University.   
 
The purpose of the research is to determine the knowledge and experience of nurses working in the acute neuroscience 
wards or units within New Zealand.  As a result, the importance of oral hygiene for these patients will be highlighted with 
some key points for implementation to improve care in your area.   
 
You have received this questionnaire from you charge nurse manager or educator and is anonymous.  This anonymous 
questionnaire will take up to ten minutes to complete.   
 
You are under no obligation to complete this questionnaire.  You have the right to decline any particular question.  Please 
complete this questionnaire on survey monkey, the link is provided below.   
 
The results are collated and individual nurses cannot be identified.  The data collected will be kept on a password protected 
computer.   
 
If you wish to obtain a copy of the results of this research, please email caroline.woon@ccdhb.org.nz.   
 
This project has been approved through the Massey Ethics approval application process as well as approval by the Maori 
Research committee at the local hospital and your local hospital research department.   
Appendix 1: Oral hygiene Questionnaire for Nurses 
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Neuroscience nurses knowledge and experience 
 
Are you: 
   An enrolled nurse    A Registered nurse 
 
Are you: 
   Male      Female 
 
 
Do you work on:  
   A Neuroscience ward    A neuroscience high dependency unit 
   A neuroscience Intensive care unit.   
 
What is your highest level of qualification? 
   Nursing diploma    Bachelor of Nursing 
   Bachelor of Nursing (Pacific)   Post graduate certificate 
   Post graduate diploma    Post graduate masters 
 
 
How many years of experience do you have as a nurse? 
   0-5 years                6-10 years           
   11-15 years     16-20 years            
   21-25 years     More than 25 years 
 
Which country did you qualify as a nurse?   
 
 
 
In your nursing training did you have education about oral hygiene?   
   Yes     No    Can’t remember 
 
Did you feel it was: 
   Good     Adequate   Poor 
 
 
Did you have oral hygiene training when you started on this ward or unit? 
   Yes     No    Can’t remember 
 
 
Did you feel it was : 
   Good     Adequate   Poor 
 
Do you think your knowledge of oral hygiene practices is: 
   Good     Adequate   Poor 
 
Do you have an oral hygiene assessment tool on your ward? 
   Yes     No     Unsure 
 
 
Please indicate how strongly you agree or disagree with the following statements 
 
 
I believe oral hygiene is a high priority for my patients 
 Strongly disagree  Disagree  Neutral   Agree  Strongly agree 
 
  
The oral cavity is a difficult area to clean 
 Strongly disagree  Disagree  Neutral   Agree  Strongly agree  
 
 
I find cleaning the oral cavity to be an unpleasant task 
 Strongly disagree  Disagree  Neutral   Agree  Strongly agree 
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I believe that good oral care has a significant impact on patient’s clinical outcome 
 Strongly disagree  Disagree  Neutral   Agree  Strongly agree 
  
 
I am satisfied with my oral care practices 
 Strongly disagree  Disagree  Neutral   Agree  Strongly agree  
 
 
I have been given adequate training in providing oral care 
 Strongly disagree  Disagree  Neutral   Agree  Strongly agree  
 
 
I need more information on research-proven oral care standards 
 Strongly disagree  Disagree  Neutral   Agree  Strongly agree  
 
 
Attending an in-service on proper oral care is a priority for me 
 Strongly disagree  Disagree  Neutral   Agree  Strongly agree  
 
 
There are often other procedures my patients require more urgently than oral care 
  Strongly disagree  Disagree  Neutral   Agree  Strongly agree 
  
 
I assess the oral health of my patients regularly 
  Strongly disagree  Disagree  Neutral   Agree  Strongly agree 
  
 
I would like an oral assessment tool to assist me to assess oral health 
 Strongly disagree  Disagree  Neutral   Agree  Strongly agree  
 
 
What barriers have you experienced to providing oral care for your patients?   
   Uncooperative patients   Unstable patient  Inadequate staffing 
   Lack of products available  Lack of knowledge  It is an unpleasant task  
   Time      Difficult to access the oral cavity 
   Other (please specify) 
 
 
What products do you routinely use for oral hygiene? 
   Manual Toothbrush   Foam swab   Gauze 
    Electric Toothbrush   Toothpaste   Mouthwash  
   Vaseline/Vitamin A   Cocoa butter   Sodium bicarbonate 
   Artificial saliva    Denture cleaning tablets Soap 
   Coconut oil 
  
Describe what oral care, what products you would use and how often, you would provide for: 
 
A patient with their own teeth who is unable to perform their own oral care…..  
 
A) and has difficulty swallowing 
Frequency 
   Once daily    Twice daily   8 hourly   
   4 hourly    2 hourly   1 hourly 
Products 
 
   Manual Toothbrush   Foam swab   Gauze 
    Electric Toothbrush   Toothpaste   Mouthwash  
   Vaseline/Vitamin A   Cocoa butter   Sodium bicarbonate 
   Artificial saliva    Denture cleaning tablets Soap 
   Coconut oil 
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 B) has a dry mouth and lips and is unable to perform their own oral care 
Frequency 
   Once daily    Twice daily   8 hourly   
   4 hourly    2 hourly   1 hourly 
Products 
   Manual Toothbrush   Foam swab   Gauze 
    Electric Toothbrush   Toothpaste   Mouthwash  
   Vaseline/Vitamin A   Cocoa butter   Sodium bicarbonate 
   Artificial saliva    Denture cleaning tablets Soap 
   Coconut oil 
   
C) A patient who has a full set of dentures  
Frequency 
   Once daily    Twice daily   8 hourly   
   4 hourly    2 hourly   1 hourly 
Products 
   Manual Toothbrush   Foam swab   Gauze 
    Electric Toothbrush   Toothpaste   Mouthwash  
   Vaseline/Vitamin A   Cocoa butter   Sodium bicarbonate 
   Artificial saliva    Denture cleaning tablets Soap 
   Coconut oil 
  
  
Please circle which of the following are available in your ward/area 
   Toothbrush    Foamstick   Gauze 
   Toothpaste    Mouthwash   Vaseline/Vitamin A 
   Cocoa butter    Sodium bicarbonate  Artificial saliva 
   Denture cleaning tablets  Soap    Coconut oil 
  
Please list any other products available for you to use for oral care 
 
 
Is there a dental team in the hospital?  
   Yes     No    Unsure 
 
 
When would you contact the dental team about your patient?   
 
 
 
In your ward who is responsible for providing oral care for patients? 
   DR     Nurse    HCA   
   Student 
 
What complications can be caused through poor oral hygiene?   
 
 
How confident do you feel with doing the following? 
 
A) Cleaning the teeth of your patients 
   Not at all confident  Not sure  Confident  Very confident 
 
B) Caring for dentures 
   Not at all confident  Not sure  Confident  Very confident 
 
C) Assessing oral care needs 
   Not at all confident  Not sure  Confident  Very confident 
 
D) Giving oral care advice to your patients 
   Not at all confident  Not sure  Confident  Very confident 
 
E) Giving oral care advice to your colleagues 
   Not at all confident  Not sure  Confident  Very confident 
 
Thank you for your time and help with this project 
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Introduction: 
 
When thinking about head injury, one needs 
to first understand forces and the way they 
impact the body. Gravitational force, or G-
force, is the force of gravity on a particular 
body – a measurement (in G’s) of accelera-
tion that causes the perception of weight. It 
has significant applications in scientific & en-
gineering fields especially regarding racing 
cars, fighter jets, large engines and roller-
coasters.  
 
It is interesting to note (see table below) that 
the force of gravity whilst just standing on the 
earth, increases markedly with a slap on the 
back. Then further when in a car or a roller-
coaster and even more if having sustained a 
concussion.   
 
In today’s modern age, Sir Isaac Newton’s 
theories and laws are still included in the cur-
riculum taught to students at school. From his 
theories of optics and calculus, to his ground-
breaking work on the laws of motion and 
gravity, which formed the basis for modern 
physics, he dominates the fields of science, 
astronomy, physics and the natural world, 
proving invaluable to centuries of mathemati-
cians, engineers and scientists. 
In health, the Valsalva manoeuver is a tech-
nique of force used to equalise pressure 
(Pstras et al, 2016). People perform the 
Valsalva manoeuver regularly without know-
ing it. For example, it is used to increase co-
lonic pressure to induce a bowel movement 
and it may also be beneficial when used in-
tentionally to try to regulate heart rhythms. It 
is also used when experiencing a change in 
altitude to help equalise the ears by forcing 
them to ‘pop’, such as when scuba diving or 
in aeroplanes. The main side effect of per-
forming the Valsalva manoeuver is hypoten-
sion and resultant forces impacting intra-
ocular, intra-abdominal and intra-cerebral 
pressure.  
 
 
Abstract 
 
The thrill to go fast and push boundaries is something that many seek. From John Stapp’s rocket 
sled at Edwards Air Force Base in the late 1950’s to todays’ Formula 1 drivers, the “need for speed” 
is broadcast across TV screens weekly. So too are the horror stories of crashes, many at over 
300km/hr. Yet “need for speed” continues. It appears that the higher and faster the rollercoaster, 
the better. This leads to several questions. How does the brain stand up to speed and G-forces? Do 
Newton’s Laws still have reference in today’s world?  
 
There has been much attention in the general press on the possibility that high G-force roller-
coasters are inducing brain injury in riders. However, research does not wholeheartedly support this 
notion, but rather the risk of brain injury from a rollercoaster is not in the rides, but in the rider – 
caused by previously undetected brain or neck conditions. That said there is some truth that high G
-forces do affect the brain at a chemical and structural level. 
 
This paper will discuss the mechanism of head injury at speed and generally what Newton’s Law 
means in a neurological setting in todays’ world. Formula 1 racing and rollercoaster rides will be 
evaluated within a neuroscience context.  
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These forces are also produced in the acts of 
vomiting, coughing and sneezing. As neuro-
science nurses, the knowledge regarding the 
impact of these forces is known to be trouble-
some in relation to the consequences of 
these forces on intra-cerebral pressure and 
the homeostasis of the brain. It should be 
kept in mind that the involuntary act of sneez-
ing has ramifications from a G-force perspec-
tive. The act of sneezing with an open mouth 
has a force of 2.9G’s. Yet holding in a sneeze 
internally redirects the force and this can re-
sult in eye injury, ruptured ear drum, herniat-
ed nucleus pulposis (herniated disc) and 
throat injury (Yang et al 2018).  
 
Table 1: How Many G’s? 
Adapted from Slade (2009) 
 
Newton’s First Law: (Inertia). An object will 
remain at rest, and an object will remain in 
motion, unless acted upon by an unbalanced 
force. For example, a fast car hits a brick 
wall. The car stops…but the person does not. 
Since an object at rest stays at rest, roller-
coasters have to be pushed or pulled along 
the track. In this way, potential energy is 
stored for the entire ride. At the top, the 
rollercoaster is put into motion and will not 
stop until the brakes are applied at the end of 
the ride. 
 
The world’s fastest rollercoaster is the For-
mula Rossa rollercoaster in Ferrari World, 
Abu Dhabi, United Arab Emirates. It is 53m 
high and has a maximum speed of 240km/h 
via a hydraulic slingshot launch. In this way, 
acceleration is 0 to 240km/h in 4seconds. 
The G-force is 4.8G, requiring the rider to 
wear goggles for eye protection.  
 
Newton’s Second Law: (Force = mass x 
acceleration). This law explains how the ve-
locity of an object changes when it is subject-
ed to an external force. This is felt when go-
ing down hills. The coaster cars and your 
body have mass. The gravity provides accel-
eration, which causes force. The rider feels 
the force as it moves the cars along the track. 
The track directs the force and the cars. In 
positive G’s, the body feels heavier – at the 
bottom of the hills, turns and loops. For ex-
ample, a 70kg person at 2G’s would have the 
perception of 140kg and at 3G’s it would feel 
like 280kg. Whereas with negative G’s, the 
body feels weightless – at the top of the hills.  
 
Newton’s Third Law: (Action/reaction). For 
every action (force), there is an equal and 
opposite reaction. For example, as your body 
is pushed down into the seat of the roller-
coaster, the seat pushes back. 
 
Newton’s Laws permiate throughout engi-
neering and science fields and are still cur-
rent in today’s practice. It was Dr John 
Stapp, a United States Air Force Colonel, 
flight surgeon, physician, biophysicist, and 
pioneer in studying the effects of acceleration 
and deceleration forces on humans, who put 
Newton’s Laws to the test on the human 
body.  
 
At New Mexico’s Air Force Base, December 
10, 1954, John Stapp was strapped into the 
Sonic Wind rocket sled. His arms and legs 
were secured. There was no windscreen, so 
he wore goggles, a mouthguard and a hel-
met. The sled was powered by nine solid fuel 
rockets and it fired and propelled him more 
than 3,000 feet in a few seconds. He came to 
an abrupt stop and experienced a force 
equivalent to 46.2 G. Not without injury, he 
walked away with the world land speed rec-
ord, 632 miles/hour, which he still holds to-
day, giving him the title of  "the Fastest Man 
on Earth" (Atwell, 2017). However, the blood 
vessels in his eyes had burst, rendering him 
temporarily blind. He also sustained bilateral 
wrist and rib fractures.  
 
The outcome of these experiments allowed 
for the development of improved pilot har-
nesses and aircraft seats, modern crash-test 
dummies, the ejection seat and high-altitude 
pilot suits. Stapp’s research improved aircraft 
safety and also led to the development of the 
shoulder seat belt. In September 1966, Presi-
dent Johnson, with John Stapp present, 
signed the Highway Safety Act, in which it 
was required that all new cars, as of 1968, 
sold in the USA, be fitted with seat belts 
(Ryan, 2015).  
 
When thinking of acceleration, the picture 
that formulates is usually of a sports car do-
ing 0 to 60 in six seconds. However, acceler-
ation is any change in the velocity of an ob-
ject – going faster, slowing down or changing 
direction. Therefore, on a rollercoaster, the G
-forces are felt when rounding tight bends 
and thrown against the side of the seat (a 
Standing on the Earth 1G 
Rollercoasters 3.5-6.3G 
A slap on the back 4.1G 
Formula 1 racing car 5G 
The luge at Whistler 5.2G 
‘Plopping’ into a chair 10.1G 
Sneezing (open mouth) 2.9G 
Concussion 80-100G 
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change in direction) just as much as when 
falling from height (accelerate) or screeching 
to a stop (decelerate). The thrill is felt, but 
there is no fainting, because the rollercoaster 
was designed to be within the G-force toler-
ance of the average person. However, the 
amount of tolerable G-forces differs by indi-
vidual and it also depends on several factors: 
the direction in which the G-forces are felt, 
the amount of G's involved, and how long 
those G's last (Evans, 2002). 
At sea level, or 1 G, humans require 22 milli-
meters of mercury blood pressure to pump 
sufficient blood from the heart to the brain. In 
2 G's, twice that pressure is needed, in 3 G's, 
three times, and so on. Even with a G-force 
of 4 or 5, the heart struggles to summon the 
necessary pressure. Blood pools in the lower 
extremities and the brain fails to be ade-
quately oxygenated. Most people then faint. 
Fighter pilots can handle greater head-to-toe 
G forces—up to 8 or 9 G's—and for longer 
periods by wearing anti-G suits. These spe-
cialised suits use air bladders to constrict the 
legs and abdomen during high G's to keep 
blood in the upper body. Fighter pilots can 
further increase their G-tolerance by training 
in centrifuges, which create artificial G's, and 
by learning specialised breathing and muscle
-tensing techniques. Magnitude and duration 
of the forces are as critical as direction. 
Whilst John Stapp showed that people can 
withstand much higher G-forces than had 
long been thought, there is a limit to what 
most people can tolerate. 
 
Princess Diana was a catastrophic example 
of how G-forces affect the human body. It 
was estimated that the G-forces on her chest 
were around 70 G's and 100 G's on her 
head. The acceleration caused a fatal tear in 
her pulmonary artery. If Princess Diana had 
been wearing a seatbelt, the G-forces would 
have been less and she may have lived. 
(Operation Paget Report, 2009).  
 
While Formula 1 (F1) racing drivers may feel 
around 5-G’s, under heavy braking, they can 
experience over 100-G’s if a crash causes 
them to decelerate quickly over a short dis-
tance.  
 
The weekend of May 1st 1994, during the San 
Marino Grand Prix, was Formula 1’s worst 
race weekend in history. That weekend of 
racing in Imola, Italy, saw the death of Austri-
an, Roland Ratzenberger in practice and that 
of Brazillian, Ayrton Senna the following race 
day. 
 
Niki Lauda spoke these words in 1994 after 
Ratzenberger crashed at over 306kph during 
qualifying and 24hrs later, Senna died when 
his car slammed into a concrete wall at 
220kph. Both died as a result of catastrophic 
head injuries. Following these deaths, F1 
underwent many changes from car design to 
fuel and tyres. There hadn’t been any deaths 
on the F1 circuit since 1994, but that came to 
an end in 2015 during the Japanese Grand 
Prix, when 25yr old driver Jules Bianchi 
crashed at 258kph and sustained severe 
head injuries. He succumbed to these injuries 
a few months later. The G-force sensor locat-
ed in his earplugs recorded a 92-G impact 
(Bednall, 2014), much greater than the hu-
man body is designed to withstand. 
 
G-forces act on blood and blood vessels. 
Just as they push the body into the seat, they 
also push the blood back away from the brain 
and toward the feet. Therefore, astronauts 
wear a pressurised G-suit that prevents 
blood pooling in the extremities. This is simi-
lar to anti-thrombotic stockings that can be 
worn for long-haul flights. If G-forces are 
brief, the effects on the body will be less. It is 
when G-forces linger, or are sustained, that 
causes concern. Hence, during launches of 
the space shuttle, controllers keep the shut-
tles’ acceleration low—no greater than 3-G's, 
so as not to unduly stress the astronauts.  
 
The eyes are especially susceptible to G-
forces and some of the first signs of problems 
in the cockpit arise from partial loss of vision. 
Pilots know it as ‘greyout’ – greying of vision 
due to reduced blood flow to the eyes. This 
can serve as a warning of the decreased 
blood flow to the head. Consciousness is 
maintained but blood flow to the eyes is com-
promised. However in some studies, half the 
pilots experienced unconsciousness at the 
same time as the loss of vision, therefore a 
 
There is a limit to what humans can take. 
Tragically, Princess Diana proved that. 
 
 
“God has had His hand over Formula 1 
for a long time.  
This weekend, He took it away”.                      
Niki Lauda – Reuters, 1994. 
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pilot cannot rely on visual disturbances to 
warn them of unconsciousness.  
 
‘Blackout’ or loss of consciousness occurs 
when cerebral blood flow is reduced. In many 
centrifuge studies, the pilots were amnesic to 
the events of losing and gaining conscious-
ness. Symptoms may include convulsive 
movements and slumping in the seat. This 
could be dangerous if falling against the con-
trols. However, it is an individual experience 
whether or not consciousness is maintained. 
Tolerance is related to the rate of onset of 
acceleration and to the duration of exposure. 
Individual tolerance depends on factors such 
as the height of the person, age, elasticity of 
the blood vessels, training, the responses of 
the heart and blood vessels, and general 
health. G-forces can also detach a retina.  
 
What do some animals have that humans 
don’t? 
 
Drake et al (2016) describe that the bighorn 
sheep, as a part of fighting and mating, rou-
tinely experience violent impacts to the head 
without negative consequences to their 
brains or horns. Their horns consist of a bony 
material and a trabecular mesh-like structure 
which absorbs the impact that occurs during 
ramming. The woodpecker too has significant 
internal structures that absorb the impact of 
pecking a tree at over twenty times per sec-
ond. Their secured hyoid bone, uneven beak 
and tight cranial cavity absorb the shock. It is 
from studying these two animals in particular, 
that the researchers have developed im-
proved mouthguards, helmets and flight data 
recorder cases. The European Organisation 
for Civil Aviation Equipment Committee, an 
international body on which the Australian 
Transport Safety Board (ATSB) was repre-
sented, revised the standards of flight data 
recorders in 2003. Today, these flight data 
recorders are able to withstand an accelera-
tion of 3,400 Gs (3,400 times the force of 
gravity) (ATSB, 2014).  
 
So where does the literature stand with 
regard to brain injury and rollercoasters? 
 
In 2002 Smith & Meaney suggested that the 
human body can withstand very large G-
forces when they occur over very short peri-
ods of time, which is the current thought to-
day. They suggested that the loss of con-
sciousness is from restriction of blood flow 
rather than mechanical injury to the 
brain. Their studies illustrated that to injure 
the brain, there needs to be greater linear 
force (G’s) as well as rotational force. They 
went on to say that neck or back injuries 
would be far more likely than brain injuries 
from rollercoasters. 
Again, the thought in 2003 was that the risk 
of brain injury from a rollercoaster is not in 
the rides, but in the rider – caused by previ-
ously undetected brain conditions or spine 
injuries from the force in the turns. (Brain In-
jury Institute of America, 2003) 
 
Yamakami et al (2005) and Roldan-Valadez 
et al (2006) described anecdotal case reports 
of potential causal relationships of patients 
suffering brain bleeding around the time of 
riding a rollercoaster. This is now not sup-
ported by epidemiological or scientific data.   
 
Although Roldan-Valadez et al (2006) pre-
sented a paediatric patient with a subdural 
haematoma, fourteen days after having rid-
den a rollercoaster, the causative element 
cannot be correlated entirely to the roller-
coaster. The results are also limited as there 
was only one individual in this study.      
 
Pfister, et. al.,  (2009) also agreed that it’s not 
the ride, but the rider and said that there was 
an  extremely low risk of TBI due to head mo-
tions induced by roller coaster rides. Similar-
ly, Kuo et al (2017) suggested that roller-
coaster rides do not present an immediate 
risk of acute brain injury. However, head mo-
tion and brain deformation during rollercoast-
er rides are highly sensitive to individual sub-
jects - who already are predisposed to brain 
injury.  
 
However, in 2018 there was a growing con-
cern about the G-force that is exerted on 
people as they ride these faster rollercoast-
ers, as the desire to go faster is ever-present. 
In October 2018, New Jersey, USA became 
the first state to limit G-forces on theme park 
rides.  
 
The American Association of Neurological 
Surgeons has assembled a national commit-
tee of neurosurgeons, NASA scientists and 
engineers that are now looking at how the 
stress of G-forces from rollercoasters might 
affect the brain, specifically how the brain is 
bounced around inside the skull on these 
rides. The committee has not yet reached 
any conclusions (ABC news, July 2018).  
 
Zhu et al (2014) describes the studying ani-
mals such as the barbary sheep and wood-
peckers have given insight into how these 
animals cope with extreme force impacts. 
Inspired by the woodpecker’s head, re-
searchers have developed a casing for air-
craft flight recorders that can withstand a G-
force of up to 60,000-G’s (previously 3,400 
G’s).  
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Conclusion: 
  
Being wrapped in cottonwool is not an option. 
Sport and fun are synonymous. The desire to 
go fast is thrilling and it seems that the faster 
the rollercoaster, the better! Keeping a child 
safe is a parent’s obligation and companies 
have that same obligation of safety. As 
demonstrated by Stapp in the 1950’s, hu-
mans can be subjected to high G-forces and 
survive, as long as it is for a short duration. 
Magnitude and duration are as critical as di-
rection, when it comes to forces. Safety is 
paramount in industries where G-forces are 
found – engineering, space travel, F1 racing 
and theme parks. With this in mind and 
knowing the mechanism of injury, F1 re-
sponded with changes to car design and 
changes to rules and procedures following 
driver injury.  
 
Rollercoasters that generate G-forces for the 
pursuit of fun-filled terror must be conscious 
of the pressure that is placed on the human 
body during these rides. Safety mechanisms 
and short duration of twists, turns and speed, 
must be taken into account and adapted for 
the safety of all.  
 
 
With this knowledge of G-forces, people are 
better placed to judge whether or not to put 
their bodies through these forces. It must al-
so be clear that if a person knows or sus-
pects they might have a brain or neck injury, 
then obviously it is unwise to participate in an 
activity that could compromise their health. 
Warnings at each ride are placed for a rea-
son, informed knowledge and decision-
making as well as coverage for litigation pur-
poses. These must be taken seriously, as it is 
a fine line between being well and unwell. 
 
Neuroscience nurses play a role in teaching 
the public – through seminars, school educa-
tional sessions and governments and compa-
nies have an obligation for public safety. Alt-
hough life is becoming a minefield of “Safe 
Operating Practices” and every product has a 
warning attached, fun activities are encour-
aged, just within reason. The brain, within its’ 
hardened case, is protected but also vulnera-
ble to changes in pressure and force. Pre-
existing conditions of the brain or neck, 
whether known or not, plays a role in injury 
from rollercoasters and theme park rides. 
Some obligation must rest with the individual. 
That is, the issue remains with the rider - 
their health and informed decision on wheth-
er or not to ride.  
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Save the Date! 
Date: 11-13 November    Melbourne 
Theme: The heart of Neuroscience Nursing 
 
Movement Disorders 
Neurology and Stroke 
Neurosurgery and Critical Care 
 
This year ANNA bring you a combined conference with a 
three day program which includes movement disorders 
as well as all aspects of neuroscience nursing.  Why don’t 
you consider presenting a local project or subject of 
interest to you and inspire others! If its your first time, no 
problem, we are here to support you. Or simply come and 
enjoy the conference and networking opportunity.  Be 
inspired!   
 
https://www.anna.asn.au/ 
Australasian Journal of Neuroscience  Volume 30 ● Number 1 ● May 2020 
 31 
A Call for abstracts 
 
First time presenting at a conference?  No problem, come and 
present to a supportive nursing community at the Australasian 
Neuroscience Nurses Association (ANNA) conference in Melbourne 
2020!  You will be given 15 minutes to present.  You may also 
choose to enter a competition to win an award as a financial 
member of ANNA! 
 
You may also choose to design and print a poster to display at the 
conference of your fantastic work.  There will be time to explain your 
poster during one of the breaks.   
 
Whichever presentation method you choose, the abstract must be 
submitted by 1 May 2020 of no more than 300 words.  All papers 
presented must be original work and will become property of the 
Australasian Neuroscience Nurses Association and reviewed for 
suitability for publication in the Australasian Journal of 
Neuroscience.   
 
Please submit your abstract via the website: 
 
https://www.anna.asn.au/abstract-submission-guidelines/ 
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Introduction: 
 
Parkinson’s disease (PD) is a progressive 
neurological disorder caused by the loss of 
dopamine producing cells in the substantia 
nigra, which is located in the basal ganglia. 
As dopamine assists with transmitting and 
modulating signals in the brain, ongoing do-
pamine depletion causes motor, autonomic 
and cognitive impairments (Magrinelli et al., 
2016). PD is characterised by motor symp-
toms that are associated with movement 
(e.g. bradykinesia, rigidity, postural instabil-
ity, tremor) (Magrinelli et al., 2016), and non-
motor symptoms (e.g. mood/cognitive prob-
lems, depression, pain, sleep problems) 
(Schapira et al., 2017). Motor symptoms are 
considered the clinical manifestation of dopa-
mine insufficiency and used for PD diagnosis 
(Chenoweth, Sheriff, McAnally, & Tait, 2013; 
Queen, 2017; Schapira, Chaudhuri, & Jen-
ner, 2017). However, non-motor symptoms 
can become more debilitating than motor 
symptoms as PD progresses (Chenoweth et 
al., 2013; Schapira et al., 2017). 
 
A recent epidemiological study indicated up 
to 212,000 people (1 in 117 people aged 
over 50 years) are living with PD in Australia, 
with more than one million caregivers, family 
and friends directly impacted by the condition 
(Ayton et al., 2019).  
 
 
 
 
Abstract 
 
Background: Individuals with Parkinson’s disease (PD) have more hospital admissions, longer 
hospital stay, more complications and worse outcomes compared with similar patients without 
PD. Limited understanding about PD among healthcare professionals and medication manage-
ment are key issues for individuals with PD. 
 
Methods: This study presents a collaborative clinical practice improvement project that was im-
plemented in a hospital in New South Wales, Australia (September 2015 to May 2018) to resolve 
issues for patients with PD on admission to hospital. Innovative interventions were implemented 
to address specific issues identified in the study setting, including an emergency department pa-
tient tracking icon, early referral to pharmacists and measures to ensure on-time medication ad-
ministration and avoidance of contraindicated medications. Qualitative and quantitative data were 
collected through focus group discussions with PD support group members, surveys involving 
nurses and patients/carers and a chart audit. Data were analysed using descriptive statistics. 
 
Results: These initiatives resulted in practice improvements including identification of 100% of 
patients with PD presenting/admitted to hospital within 4 hours of presentation/admission, a 19% 
increase in patients receiving medications on time, an 89% reduction in prescription of contraindi-
cated medications and reduced length of hospital stay. In addition, 80% of patients/carers report-
ed they were very satisfied with their medication management. 
 
Conclusion: Patient safety was improved and clinical staff expressed satisfaction with care provi-
sion. The initiatives were also standardised across the hospital in a clinical guideline for the care 
of patients with PD. 
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The associated economic burden in 2014 
was almost $1.1 billion and accounted for 
53% of all health system costs (Deloitte Ac-
cess Economics, 2015); this burden is ex-
pected to rise. Nursing home and inpatient 
hospital care comprise the largest compo-
nent of these costs (Bohingamu Mudi-
yanselage et al., 2017; Deloitte Access Eco-
nomics, 2015; Oguh & Videnovic, 2012).  
 
The insidious onset, no known cure, and pro-
gressive nature of PD mean it is challenging 
to treat and requires a multidisciplinary ap-
proach (Bramble, Carroll, & Rossiter, 2018). 
In the inpatient context, a lack of specialist 
knowledge and low adherence to PD medi-
cation regimens can result in poor clinical 
outcomes such as extended recovery time, 
worsening symptoms, falls and morbidity 
(Cohen & Smetzer, 2015; Donizak & McCa-
be, 2017; Grissinger, 2018). These adverse 
events can result in longer hospital stay, re-
presentations and re-admissions, and in-
creased health system costs (Donizak & 
McCabe, 2017; Harris & Fry, 2017). Other 
concerns include shortfalls in the care provid-
ed and the lack of knowledge about PD in 
the healthcare team (Gill & Kitson, 2016). 
 
A recent Australian study by Harris and Fry 
(2017) suggested education and orientation 
programs should be more specific to PD and 
identified a need for evidence-based clinical 
guidelines to support earlier detection and 
management of PD in the inpatient setting. 
Greater collaboration among the healthcare 
team (including pharmacists) was also need-
ed to improve medication administration 
practices and avoid potential adverse events 
(Harris & Fry, 2017). It is important to identify 
a person with PD at presentation/admission 
to hospital so staff can be alerted to that per-
son’s particular needs (e.g. time-critical med-
ications). An early warning system means 
strategies can be implemented to ensure 
medications are available without delay 
(Aminoff et al., 2011; Gerlach, Winogrodzka, 
& Weber, 2011; Harris & Fry, 2017). This 
paper presents a collaborative clinical prac-
tice improvement project that was imple-
mented to raise awareness about PD among 
healthcare professionals, facilitate inter-
professional collaboration to address medi-
cation issues and improve the care journey 
for patients with PD. 
 
Project Background 
 
This collaborative project aimed to streamline 
hospital admission for individuals with PD by 
resolving identified problems. It also aimed to 
address increasing frustration and concerns 
among hospital staff and the local PD support 
group regarding care provision for patients 
with PD. Staff at the study hospital were also 
concerned about poor understanding of the 
complexity of PD (e.g. prolonged medication 
delays can be life threatening), extended 
length of hospital stay for patients with PD 
and reported adverse medication-related 
events. These concerns were consistent with 
issues reported in the literature (Donizak & 
McCabe, 2017; Oguh & Videnovic, 2012). 
 
In New South Wales (NSW), Australia, a part
-time Parkinson’s Clinical Nurse Consultant 
(CNC) services four hospitals (a 292-bed 
regional base hospital and three peripheral 
hospitals) along with nursing homes, commu-
nity visits and a multidisciplinary clinic, with-
out specific neurology support. This project 
was motivated by the Parkinson’s CNC in 
response to concerns raised by clinicians 
and consumers.  
 
Project Aim 
 
In the study hospital it was considered im-
portant to identify individuals with PD on 
presentation to the emergency department 
and improve staff knowledge and medication 
administration practices (Aminoff et al., 2011; 
Gerlach et al., 2011; Harris & Fry, 2017). 
Specifically, this project aimed to ensure that: 
individuals with PD presenting to the study 
hospital were identified within 4 hours of 
presentation/admission; essential medication 
was available in the emergency department; 
patients received medications on time; and 
contraindicated medications were not admin-
istered. The study outcomes included pa-
tient/carer satisfaction with medication man-
agement, reduced adverse events/incidents, 
and identification of individuals with PD on 
presentation to hospital. 
 
Methods: 
 
Following engagement with hospital and com-
munity stakeholders, a clinical practice im-
provement team was formed to address iden-
tified problems relating to effective PD care 
provision. The reporting of this study was 
consistent with the SQUIRE guidelines 
(Ogrinc et al., 2016). 
 
Project Setting and Implementation Team 
 
This project was conducted from September 
2015 to May 2018 at a regional teaching hos-
pital in New South Wales, Australia. The hos-
pital provides a range of services including 
emergency medicine, general medicine, sur-
gical, obstetric, paediatric, rehabilitation and 
intensive care services. Specialist services 
include an acute stroke unit, a coronary angi-
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ography unit, a renal unit, a mental health 
unit and oncology and radiotherapy services. 
The project was conducted in collaboration 
with the local Parkinson’s Support Group and 
Parkinson’s NSW. The multidisciplinary pro-
ject implementation team was recruited from 
across the study hospital (e.g. emergency, 
medical and surgical wards, and the hospital 
quality unit) and comprised a range of clini-
cians including doctors, nurses, a speech 
pathologist, a dietician, occupational thera-
pists, physiotherapists and pharmacists. The 
team was co-led by the CNC, an occupational 
therapist and a pharmacist, and supported by 
the hospital executive. The project team in-
cluded two members of the local PD support 
group to ensure consumer engagement 
throughout. 
 
Participants 
 
Purposive sampling was used to recruit par-
ticipants for the project-specific surveys. This 
sampling method captured individuals who 
had experienced the phenomenon under in-
vestigation (Yin, 2016). An opt-out method 
was used for hospital staff and patients/
carers that did not want to participate. Partici-
pants were directly approached and provided 
with information about the project. Two focus 
group discussions were held with members 
of the local PD support group, one before 
and one after project implementation (25–30 
people in each group). Focus group partici-
pants were identified and recruited through 
the support group coordinator. The inclusion 
criteria for the focus groups were member-
ship of the support group, and a diagnosis of 
PD or a carer for a person with PD. Those 
that were not members of the support group 
were excluded. 
 
The number of nurse participants ranged 
from 12–29, depending on the intervention 
measured. The inclusion criterion for nurse 
participants was nurses working in that ward/
unit. Survey completion was voluntary. In 
addition, patient/carer (n=16) satisfaction 
with medication management was assessed 
post-implementation using a short anony-
mous survey. Patient/carer participants were 
recruited during admission to hospital using 
convenience sampling. Patients/carers were 
eligible to participate if they had a length of 
stay >1 day. Discharged patients were ex-
cluded. Participants were informed that the 
survey was voluntary, and they could choose 
whether or not to participate.  
 
Interventions 
 
Specific interventions (discussed below) were 
introduced to address identified issues. The 
project followed the clinical practice improve-
ment methodology described by the NSW 
Clinical Excellence Commission, which offers 
a framework that allows clinicians to ‘review, 
identify and understand causes of the failure 
and design solutions to continuously improve 
processes of patient care’ (NSW Health, 
2019).  
 
The project process involved assessing the 
local context, Plan-Do-Study-Act cycles, audit 
and feedback, benchmarking and regular 
practice education support (Gill & Kitson, 
2016). This supported improved delivery of 
safe clinical care and enabled the team to 
build understanding of the underlying prob-
lems and gain insight into how to implement 
improvements. Clinical champions across the 
hospital were also used to educate others, 
advocate for change and translate new 
knowledge into routine clinical practice (Gill & 
Kitson, 2016; Mabey, 2013).  (See Figure 1). 
 
Grand Rounds  
 
To raise awareness of PD among hospital 
staff, education materials were developed 
through PD ‘Grand Rounds’. In this setting, 
Grand Rounds are weekly hospital-wide mul-
tidisciplinary education sessions. For this 
project, the Grand Rounds were filmed so all 
staff could access the education material. In 
the Grand Rounds, the multidisciplinary pro-
ject team provided education regarding the 
key points and interventions required for a 
person with PD when in hospital. The Grand 
Rounds also included a patient story to 
demonstrate improvements in care from one 
admission to the next. 
 
Alert System: PD Icon and Automated Refer-
ral to a Pharmacist 
 
A system was developed to alert emergency 
department staff to the arrival of patients with 
PD to support the project target of identifying 
patients with PD within 4 hours of presenta-
tion. Changes were made to the emergency 
department patient tracking board so a per-
son with PD was identified with a green PD 
icon. This was coupled with an automated 
notification system to alert the Parkinson’s 
CNC and initiate referral to the pharmacist.  
 
Medication Management 
 
Four strategies were developed to address 
identified medication issues. First, PD medi-
cations were made available in the emergen-
cy department to support administration of 
time-critical medications and avoid medica-
tion delays. This intervention aimed to en-
sure timely access to these medications, in-
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cluding after hours. Second, a pictorial alarm 
clock was introduced at the bedside to note 
critical medication times for inpatients. This 
was considered important as standard hospi-
tal medication round times may not match 
individualised medication plans for people 
with PD. Third, stickers for time-critical and 
contraindicated medications were developed 
for pharmacists to use on patients’ medica-
tion charts to remind staff and support the 
necessary practice change. These stickers 
provided visual cues to highlight the im-
portance of administering medications on 
time and identify the top three medications 
that should not be given to patients with PD. 
Finally, a clinical algorithm was developed to 
support switching a person’s medication 
when their ability to swallow was compro-
mised. 
 
Data Collection  
 
Qualitative data from the focus group discus-
sions were collected in field notes. The focus 
groups were facilitated by the hospital quality 
coordinator, who asked open-ended ques-
tions around hospital admission of patients 
with PD (e.g. ‘Taking PD medications while 
in hospital is important, can you tell me of 
your experiences with these medications in 
hospital?’). All focus group participants were 
encouraged to speak freely and openly. One 
focus group was held before project imple-
mentation and one was held post-
implementation. Information obtained from 
the first focus group assisted in developing 
the project interventions. The post-
implementation focus group provided oppor-
tunity for feedback on the interventions. Both 
focus groups were held in an accessible 
community venue and lasted around 60 
minutes. 
 
Quantitative data from nurses were collected 
via short self-administered paper-based sur-
veys designed by the project team. The sur-
veys were distributed after implementation of 
each intervention and collected nurses’ per-
ceptions of that intervention. For example, 
the survey distributed following PD medica-
tions being made available in the emergency 
department included questions such as ‘Has 
access to the medication been beneficial in 
providing patients their medications on time?’ 
Response options for items in all staff sur-
veys were ‘yes’, ‘no’ and ‘not applicable’. A 
free text area was provided so staff could 
offer any further comments. Before each sur-
vey, a member of the project team liaised 
with the nursing unit manager to advise them 
of the survey and seek their assistance in 
communicating with staff. The surveys were 
left on the ward/unit for nurses to complete 
on a voluntary basis. Completed surveys 
were returned via a confidential return box 
located on the ward/unit.  
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Data from patients/carers were collected us-
ing a paper-based survey (two items) admin-
istered post-implementation. One item as-
sessed if the patient had received their medi-
cations on time, with responses on a five-
point likert scale from ‘never’ to ‘always’. The 
second item evaluated patients’ satisfaction 
with their medication management, with re-
sponses on a five-point likert scale from ‘very 
satisfied’ to ‘very dissatisfied’. 
 
The chart audit monitored and evaluated 
changes in practice following the project im-
plementation. The audit was conducted be-
fore the project (January to June, 2016) and 
post implementation (September to Decem-
ber, 2016). Information collected covered: 
identification of a patient as having PD on 
admission; adverse events (e.g. aspiration 
pneumonia, falls, contraindicated medica-
tions given); current medications charted on 
admission; medications administered on time 
(yes/no/not documented); and pharmacist 
review after admission to the emergency de-
partment.  
 
In total, 22 charts were reviewed. The chart 
audit was conducted by the project team co-
leaders. Charts were included in the audit if 
they were for patients with a diagnosis of PD 
as determined by a neurologist, geriatrician 
or rehabilitation/medical physician, and iden-
tified in the hospital electronic medical record 
system or by hard copy records. In addition, 
length of stay data were collected from hos-
pital records for September 2015 
(commencement) and 2016 (the year after 
project commenced).  
 
Data Analysis 
 
Qualitative data obtained from the focus 
group discussions were analysed using the-
matic analysis. Quantitative data were ana-
lysed using descriptive statistics. Any survey 
questions with missing data were excluded 
from the analyses. The chart audit data rep-
resented approximately 20% of patient ad-
missions (the hospital admits >100 patients 
with PD each year), but no power calculation 
was used to determine the sample size. 
These data were entered into a Microsoft 
Excel spreadsheet, and descriptive statistics 
(frequencies and percentages) were calculat-
ed. Any missing data from the chart audit 
were managed by cross checking the data 
with paper/electronic medical records. 
 
Ethical Considerations 
 
As this was a quality improvement project, 
formal ethics approval was not required. 
However, approval to conduct the project 
was obtained from the study hospital execu-
tive. For nurse and patient/carer participants, 
return of a completed questionnaire was con-
sidered as provision of consent. All patient 
data were de-identified and aggregated be-
fore analysis. 
 
Results: 
 
The project interventions resulted in a num-
ber of improved outcomes. The qualitative 
data obtained from the focus groups are dis-
cussed first, followed by the main results for 
each of the interventions. 
 
Focus Group Discussions  
 
The main themes that emerged from the pre
-implementation focus group included medi-
cation management, basic care, the human 
factor and communication. Concerns were 
voiced about the inadequacies and shortfalls 
of the hospital system. These data were 
used to inform the project interventions. 
 
The post-implementation discussion provid-
ed opportunity to gather feedback from 
group members on the interventions. The 
main themes that emerged from this discus-
sion were increased awareness among hos-
pital staff of the specific needs of people with 
PD from the start of the care journey, the 
importance of medication timing and im-
provement in the overall care experience. 
The different comments made by participants 
in the first and second focus group discus-
sions reflected the interventions. For exam-
ple, a comment from the first focus group 
was:  
 
‘The staff in emergency don’t seem to 
know very much about Parkinson’s 
and the importance of medication tim-
ing; it took hours for the staff to get the 
medication from pharmacy for my hus-
band, and by the time he had it his 
symptoms were at their worst—very 
rigid and tremulous—and he was so 
anxious’.  
 
The feedback from the second focus group 
was markedly different: 
 
‘The staff in emergency and the 
wards have a very good understand-
ing of Parkinson’s. From the moment 
we presented to hospital, the staff 
knew my husband had Parkinson’s 
without even asking, the medications 
were given on time every time, much 
different from his other admission’. 
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Interventions: 
 
Staff Education: Grand Rounds 
 
The Grand Rounds lead by the multidiscipli-
nary project team focused on the key points 
and interventions required for a person with 
PD when in hospital. The session was filmed 
and uploaded to the health service’s elec-
tronic health education platform, which was 
available to all employees. The session was 
available for viewing by groups and on an 
individual basis. As at 16 March 2020, the 
production has been viewed 66 times. Alt-
hough formal feedback was not collected 
from staff, anecdotal evidence indicated that 
education provided, ‘a comprehensive over-
view of PD, the importance of medications on 
time and the care of patients when in hospi-
tal’.  A separate version of this education 
session was produced for the general public 
and broadcast twice via radio locally and 
around Australia, with the goal of raising pub-
lic awareness about PD.  
 
Alert System: PD Icon 
 
The target was to identify patients with PD 
within 4 hours of presentation to hospital. PD 
was first identified as a problem in the elec-
tronic medical records, and then tagged to 
the specific patient. An alert was triggered, a 
green ‘PD icon’ (Figure 2) displayed on the 
patient tracking board in the emergency de-
partment to identify a patient with PD.  
 
This resulted in marked improvement in iden-
tification of patients with PD. Post-
implementation, 100% of patients were iden-
tified on presentation to hospital (Table 1). 
This enabled earlier and increased referrals 
to pharmacists, which in turn helped to pre-
vent medication-related incidents. 
 
Figure 2. Parkinson’s disease tracking 
icon (red circle).  
Medication Management 
 
Four initiatives were implemented to improve 
clinical practice around the administration of 
medications to patients with PD. First, PD 
medications were made available in the 
emergency department to avoid medication 
delays. Post implementation, 100% of staff 
members were satisfied that this change had 
assisted in reducing medication delays and 
risk for medication errors (Table 1).  
 
Table 1. Summary of main pre- and post-
implementation differences (chart audit) 
The second medication management inter-
vention was the introduction of a pictorial 
alarm clock at the bedside to highlight critical 
medication times for inpatients (Figure 3).  
 
Figure 3: Medication management inter-
ventions. A: Pictorial alarm clock. B: 
Stickers for medication charts. 
Post-implementation, all staff (100%) report-
ed the clock had highlighted the importance 
of on-time medications (Table 2). In addition, 
93% of patients/carers reported they were 
satisfied that medications were received on-
time. The chart audit showed an increase in 
administration of PD medications on time 
from 44% at baseline to 63% post-
implementation (Table 1). 
 
Intervention Baseline Post-
implementation 
Identification of patients 
with PD within 4 hours of 
admission 
90% 100% 
Automated referral to 
pharmacist for patient 
review on admission 
27% 31% 
Prescription and admin-
istration of contraindicat-
ed medications 
44% 16% 
Contraindicated medica-
tions identified on medi-
cation charts (post-
implementation) 
- 94.7% 
PD medications adminis-
tered on time 44.4% 63.2% 
Time critical stickers used 
on medication charts 
(post-implementation) 
- 68.4% 
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The third medication management initiative 
involved a newly introduced practice where 
stickers were placed on patients’ medication 
charts to highlight time-critical and contrain-
dicated medications (Figure 3). The chart 
audit following this initiative showed the ad-
ministration of contraindicated medications 
reduced from 44% at baseline to 16% post-
implementation (Table 1). After the introduc-
tion of these stickers, there was 68% compli-
ance with the time-critical stickers and 95% 
compliance with the contraindicated stickers 
(Table 1). Over the study period, the number 
of reported medication incidents was re-
duced from 11 to 5 (Table 3). In addition, 
100% of staff agreed the stickers highlighted 
the importance of on-time medications, and 
64% reported the initiative had resulted in 
changes to their practice (Table 2). 
 
Table 2. Nursing staff responses to the medication management intervention surveys  
  Yes 
n (%) 
No 
n (%) 
Not  
applicable 
n (%) 
Contraindicated sticker (N=24)       
Have you cared for a patient with Parkinson’s disease in 
the last 2 months? 
23 (95.8) 1 (0.4)   
Have you seen the contraindicated medication sticker? 16 (66.7) 8 (33.3)   
If yes, did the sticker highlight the importance of NOT 
administering the listed medications? 
16 (66.7) 0 8 (33.3) 
If yes, did the sticker result in a change of practice? 9 (37.5) 5 (20.8) 8 (33.3) 
Did you know that these commonly prescribed meds 
were contraindicated for people with PD? 
18 (75) 6 (25)   
Did the sticker result in a change of knowledge? 10 (41.6) 8 (33.3) 6 (25) 
Time-critical sticker (N=19)       
Have you seen the time critical sticker? 15 (78.9) 4 (21)   
If yes, did the sticker result in a change of knowledge? 5 (26.3) 10 (52.6) 4 (21) 
If yes, did the sticker result in a change of practice 5 (26.3) 10 (52.6) 4 (21) 
Are the stickers user friendly? 18 (94.7)   1 (5.3) 
Medications available in the ED (N=12)       
Are you aware that medications are available in the ED? 11 (91.7) 1 (8.3)   
If yes, were you able to identify the correct medication 
for the patient? 
9 (75)   3  (25) 
If yes, has access to the medication been beneficial in 
providing the correct medication for the patient? 
9 (75)   3 (25) 
Should these medications be available in the ED on a 
permanent basis? 
12 (100)     
Has the initiative raised your awareness of Parkinson’s 
disease? 
10 (83.3) 2 (16.7)   
Pictorial alarm clock (N=18)a       
Did the alarm clock highlight the importance of the need 
to administer the meds on time? 
18 (100)     
Did the alarm clock result in a change in practise? 8 (44.4) 7 (38.9) 3 (16.7) 
Is the alarm clock picture user friendly? 14 (77.8)     
ED, emergency department; PD Parkinson’s disease. 
aAlthough 29 nurses completed this survey, responses are only included for the 18 nurses who had 
seen the alarm clock because of missing data. 
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Finally, a clinical algorithm was developed 
and implemented to support switching a per-
son’s medication when their ability to swallow 
was compromised and they were nil by 
mouth (Figure 4). This was part of a clinical 
guideline that covered the changes imple-
mented throughout the project and aimed to 
standardise PD care in the study setting 
(Bramble et al., 2018; Gerlach et al., 2011; 
Harris & Fry, 2017). Formal and informal 
monitoring of guideline compliance was im-
plemented to ensure these changes were 
sustainable. Issues with non-compliance, 
patient and carer complaints and any report-
ed adverse events were discussed and peer 
reviewed during regular team meetings over 
the subsequent 12 months.  
 
In addition to the specific interventions noted 
above, the project contributed to a reduced 
average length of stay for patients with PD. 
Hospital records showed that in 2015, there 
were 101 episodes of care for secondary 
diagnoses of PD, with a mean length of stay 
of 8.97 days.  
 
Further Improvements: 
 
In 2016, there were 149 episodes of care for 
secondary diagnoses of PD, with a mean 
length of stay of 6.22 days (Table 3).  
Patients/carers expressed satisfaction with 
medication management (Table 4) following 
the interventions.  
 
Table 3. Medication incidents and length 
of hospital stay before and during the 
project period 
 
Focus group participants also reported satis-
faction with the improved care journey. Team 
facilitators were available to provide specific 
education to each ward as needed. This edu-
cation covered the components of the clinical 
  2015 2016 2017 
Number of pa-
tients with Parkin-
son’s disease 
admitted 
101 149 112 
Number of report-
ed medication 
incidents 11 6 5 
Length of hospital 
stay (days)a 
9 6 8 
Figure 4: Clinical algorithm for patients that are nil by mouth.  
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guideline, including identification of patients 
with PD, medication management (e.g. time-
critical PD medications, contraindicated med-
ications), and managing patients who were 
nil by mouth. 
 
Discussion: 
 
This paper presents a collaborative clinical 
practice improvement project that aimed to 
improve patient safety through reducing 
medication-related errors for patients with 
PD. More broadly, this project raised aware-
ness of PD among healthcare professionals, 
improved and standardised clinical practice 
in relation to provision of care for patients 
with PD and improved patients’ journey 
through care. 
 
The interventions focused on: a patient safety 
perspective that bridged departmental and 
professional barriers, continuation of exact 
personal medication regimens, identifying 
and avoiding contraindicated medications 
and alternatives for when a person was nil by 
mouth. These changes ensured on-time ad-
ministration of medications, which is thought 
to reduce symptom aggravation and risk for 
falls (Donizak & McCabe, 2017; Gerlach et 
al., 2011; Grissinger, 2018). 
 
Throughout this project, the team had to radi-
cally rethink their approach from the presen-
tation and admission of patients with PD by 
redefining and improving service delivery to 
meet the needs of patients with PD, their car-
ers and hospital management (Stalter & Mo-
ta, 2018). Both consumers and staff reported 
they were satisfied with the changes imple-
mented as a result of the project. After the 
project, patients with PD were identified 
100% of the time, and administration of med-
ications on time improved from 44%–63%, 
the ultimate goal to reach 100% with the pro-
posed introduction of an electronic medica-
tion management system. In addition, medi-
cation incidents and adverse events were 
reduced, with the team focused on reducing 
these events to zero.  
 
The practice changes that occurred in re-
sponse to this project became core business 
and were incorporated into a clinical guide-
line for the care and management of patients 
with PD at presentation and admission to 
hospital, with the aim of maintaining mean-
ingful long-term sustained change with im-
proved outcomes (Aminoff et al., 2011; Ger-
lach et al., 2011; Harris & Fry, 2017). These 
results are promising and reflect the recom-
mendations and conclusions of other re-
search relating to the care and management 
of patients admitted to hospital with PD 
(Aminoff et al., 2011; Chenoweth, Sheriff, 
McAnally, & Tait, 2013; Chou et al., 2011; 
Cohen & Smetzer, 2015; Donizak & McCabe, 
2017). 
 
The interventions, project process and 
changes in practice described in this paper 
have gathered interest in other healthcare 
settings (both nationally and internationally) 
following presentations at national (Carroll, 
2018a) and international (Carroll, 2018b) 
Item Responses 
  Always 
n (%) 
Sometimes 
n (%) 
No 
n (%) 
Don’t know 
n (%) 
Parkinson’s disease 
medications received 
on time? 
12 (80) 2 (13.3%) - 1 (6.7) 
  Dissatisfied 
n (%) 
Neither satisfied 
nor dissatisfied 
n (%) 
Somewhat 
satisfied 
n (%) 
Very satisfied 
n (%) 
Satisfaction with 
mediation 
management 
- - 3 (20) 12 (80) 
Free text comments 
(examples) 
‘I don’t know much about my medications, just a new diagnosis’ 
 
‘They were pretty good. Wife explained to hospital staff that it was 
important that the meds be given on time’ 
 
‘Different medication to what he has at home. In hospital he was given 
a white tablet where he has capsules at home’ 
Table 4. Patient/carer satisfaction (N=15) 
aThe categories ‘Very dissatisfied’ and ‘Somewhat dissatisfied’ have been combined in the table. 
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conferences. Key elements have been incor-
porated into the study hospital’s new Elec-
tronic Medication Management System 
(NSW Health, 2018), including electronic 
prompts for contraindicated and time-critical 
medications. Initiatives such as the time-
critical prompts were subsequently incorpo-
rated in the Rural Electronic Medication Man-
agement model across six Local Health Dis-
tricts in NSW. 
 
Other unintended outcomes following the 
project included the Parkinson’s CNC be-
coming a full-time role at the study institution 
and a second Parkinson’s CNC role being 
established in the region. Issues regarding 
provision of care for people with PD identified 
and addressed in this project highlighted the 
competencies required for the Parkinson’s 
CNC role (e.g. leadership, facilitation/
education skills, person-centred care, collab-
oration, evidence-based practice and quality 
improvement). The literature suggests that 
nurses who display strong leadership and 
facilitation skills can lead practice change, 
challenge systems and boundaries and im-
prove performance and standards (Stalter & 
Mota, 2018).  
 
Strengths and Limitations: 
 
A major strength of this project was the en-
gagement of a collaborative quality improve-
ment team to develop and lead the interven-
tions. The interventions introduced have 
proved to be simple, cost effective and easy 
to replicate, and staff and consumers ex-
pressed satisfaction with the changes. Limita-
tions of this project included the small sample 
size used for the chart audit (representing 
around 25% of admissions) and the staff sur-
veys. In addition, the project would have ben-
efited from statistical support, as no power 
calculation was used to determine sample 
sizes.  
 
Conclusion: 
 
This clinical practice improvement project 
showcases the benefits of a collaborative 
team approach to solving issues for people 
with PD presenting and admitted to hospital. 
The changes in practice described in this 
paper have been formalised in a clinical 
guideline to standardise PD care in the study 
setting.  
 
Broader Implications of the Project: 
 
In April 2018, the project co-leaders made a 
submission to NSW Health and Education 
Training Institute regarding implementation of 
state-wide PD education. This was success-
ful in June 2019 and resulted in a multimedia 
education project for nursing and allied 
health staff (NSW Health, 2020a). The Park-
inson’s CNC also collaborated with the NSW 
Health Clinical Excellence Commission in 
updating the NSW Health Safety Notice for 
management of medication for patients with 
Parkinson disease to guide actions by Local 
Health Districts/Networks (NSW Health, 
2020b).  
 
A collaborative research project has also 
been established to explore the effectiveness 
of the PD specialist nurse role for people with 
PD in the wider Australian context. Finally, 
the project was the catalyst for a three-stage 
research project commissioned by Parkin-
son’s NSW in collaboration with Charles 
Sturt University. Stage one involved develop-
ing evidence-based models to support best 
practice nursing services for people with PD 
in regional NSW (Bramble et al., 2018). 
Stage two comprised investigating a model 
of care for people living with PD and compar-
ing the impact of two specialist PD nurses in 
regional NSW (Rossiter, Bramble, Matheson, 
Carroll, & Phillips, 2019). A pilot retrospective 
analysis was also conducted to explore the 
cost effectiveness of specialist PD nurses, 
with the Parkinson’s CNC as the initiating 
researcher (Bramble, Wong, Rossiter, Car-
roll, & Schwebel, 2019). Stage three focuses 
on the role of community groups supporting 
people living with PD (Carroll, 2019). 
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I first met Sharryn in 1990 in Alice Springs, 
the year Nimodopine made its first big break 
onto the scene to treat SAH. This was Shar-
ryn’s second meeting and also mine, alt-
hough my first was the previous year and 
Sharryn’s was 2 years prior. Barb Lester, a 
dear friend of the association, often reminded 
me that her first introduction to Sharryn was 
that of a very loud, eloquent and outspoken 
young nurse with enormous potential, one to 
watch.  
 
Since 1990 Sharryn seldom missed a meet-
ing, she also seldom missed a Neurosurgical 
Society meeting, which in those times were 
held back to back in the same venues. I 
know this because I too attended them and 
we quickly formed a strong friendship which 
lasted 30 years. Along with some other dear 
friends, Mary Lomas, Barbara Lester, Naomi 
Moody (Winter) and Eithne Mallon (Irving). 
We all met through our belonging to ANNA 
and were blessed to travel to all ends of Aus-
tralia and New Zealand and internationally 
with Sharryn. We enjoyed many intrepid 
times together. Lenore Saville (from Qld) 
dubbed us intrepid because we drove every-
where possible, camped under the stars and 
made the most of our times together. These 
annual jaunts were professionally rewarding 
and often hilariously entertaining.  
 
When we met Sharryn she was the Nurse 
Unit Manager of Neurosurgery at Westmead 
Hospital. Sharryn had already developed a 
great passion for learning and teaching/
mentoring. She always questioned why 
things were done the way they were and, 
where needed, ensured practices were chal-
lenged and adapted. Always done with clear 
evidence, tact and careful coercion if needed. 
She was never one to blend into a crowd or 
not express an opinion. She was to the end a 
loud and proud Neuroscience nurse.  
 
Through Sharryn’s investigative mind and 
determination to provide best practice she 
developed a love of research and presented 
many times at ANNA meetings, winning both 
the Tonnie Keonin and NSA prizes on more 
than one occasion. In past years the NSA 
prize winning paper was represented to the 
surgeons at their meeting and Sharryn’s pa-
pers were always of such a high standard 
and clinically significant value that they al-
ways generated questions and comment 
from our surgical colleagues. 
 
Those of you who may not have known Shar-
ryn well may not know that those memorable 
papers were often only finalised in the early 
hours of the morning (0300) or rising early to 
ensure her data was up to date and her 
slides were in the correct order and accurate. 
We of course plied her with Bombay Sap-
phire or wine of any colour while she tireless-
ly read through the final drafts.  
 
 
 
 
 
 
 
 
The Australasian Neuroscience Nurses As-
sociation recently lost a valued member and 
more importantly a great friend in Sharryn 
Byers. Sharryn was a long serving member 
of the association, a passionate Neurosci-
ence nurse, patient and nursing advocate. 
She was a highly committed ANNA execu-
tive member over many years at both federal 
and state levels and was a proud life mem-
ber.  
 
Sharryn was more than just a run of the mill 
member who paid her annual fees. She fell 
into Neurosurgical nursing early in her ca-
reer and fell in love with the specialty – a 
love that never left her.  
Vale Sharryn Byers 
 
Lynette Wallace  
 
Questions or comments about this article should be   
directed to Lynette Wallace C/O the Editor 
 
DOI: 10.21307/ajon-2020-005 
Copyright © 2020ANNA 
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When I first saw Sharryn present, overhead 
projectors with plastic sleeves were the audi-
ovisual of choice. With technological ad-
vancements we moved through Kodak 
Slides, CD’s and Memory sticks right up to 
current day emailing of papers. Sharryn was 
always our IT guru as she had a great capac-
ity to work through technology and solve 
problems. I recall well her assisting the NSA 
with their fledgling IT needs at their meetings.  
 
As an ANNA member, Sharryn held many 
executive posts and sat on many committees 
and conference organising working parties at 
both state and federal level. She was part of 
the association’s first multi state executive, 
using email, skype and the old fashioned tel-
ephone to stay in touch. She was always one 
to demonstrate the ethos that ‘the more you 
put in the more you got back’. Through partic-
ipation at these levels Sharryn and I, along 
with many others, have become lifelong 
friends and will continue to share many fond 
memories of times together.  
All ANNA members are also members of the 
World Federation of Neuroscience Nurses 
Association, Sharryn was also an avid at-
tendee and presenter at these meetings and 
travelled widely. At the meeting in Opatia, 
Croatia, she was mentioned in a keynote 
speech as a world leader in her field along 
with Joanne Hickey, Linda Littlejohns, Virgin-
ia Prendergast and our own Vicki Evans-
Roach. This meant the world to Sharryn, who 
had held these leaders in high esteem and 
was humbled to be mentioned in the same 
light as her own heroes. 
 
Conference adventures: Sharryn and I along 
with Mary, Barb and Naomi attended many 
conferences frequenting many wineries and 
amazing places along the way. International 
driving on the wrong side of the road, staying 
in the quaintest of B&B’s which only Sharryn 
could source.  
 
Sharryn was never a morning person and on 
our journeys would sleep the first driving leg 
and take the last leg. I was the early riser and 
would constantly need to drag her out of her 
bed to hit the road. She was always last to be 
ready. 
 
During the many years we all spent together 
children and grandchildren were born and 
weddings were had. Sharryn’s son Michael 
was her greatest achievement and we all 
knew of Michael’s adventures and loves. 
Sharryn was able to see Michael marry his 
soul mate Sarah just weeks before she 
passed away, this was her greatest thrill and 
she valiantly stood at his side resplendent in 
her favourite colour (Green).  
 
I was also privileged to get to know Sharryn’s 
brother William and sister in law Anita and 
their three amazing children. She was partic-
ularly close to Emma, her niece who also 
sadly passed away recently. Both Emma and 
Sharryn were thrilled to see Emma’s broth-
ers, Sharryn’s nephews, having children of 
their own. Sharryn loved her family to the 
moon and beyond and their closeness was 
so clear to all who knew them.  
 
Sharryn also had a passion for cooking, cake 
making and decorating. She always made 
the family wedding cakes and Christmas 
cakes and we joked prior to Sharryns passing 
that the fruit would have been soaking in 
brandy somewhere at home and they needed 
to ensure it was found and used. 
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In the weeks prior to Sharryn’s passing she 
was able to stay at home with the help of 
family, friends and colleagues who stayed 
overnight and around the clock to ensure she 
could stay at home as long as possible. I 
know you all know who you were, but Shar-
ryn was very grateful for all the care and love 
she was shown. I recall calling one day to 
find she was holding court with Kylie Wright 
and Maureen Edgtton-Winn. She called me 
back later to tell me she had had a lovely af-
ternoon. I know there were many more such 
visits from ANNA friends and colleagues. 
 
In Sharryn’s work life she was an amazing 
mentor and friend to her staff. I was privi-
leged to meet many of her work colleagues, 
who were all heartbroken at the thought that 
she was not going to be there to help and 
guide them. Many told me how she encour-
aged them to apply for their jobs and present 
papers or even teach junior colleagues at the 
bedside. The Executive DON of Nepean 
came to visit and was also saddened to know 
she was losing a friend. She told me that 
Sharryn was one of her greatest inspirations. 
Sharryn’s battle with cancer was a long and 
brave journey. She had fought and won the 
first battle only to have the beast return.  
 
 
Sharryn fought on her own terms and always 
told us that she would know when it was time 
to leave. She died on November the 19th 
2019 in her much loved Nepean hospital sur-
rounded by her family and with the full 
knowledge that she had achieved all she 
could and had lived and amazing life. Many 
of you will appreciate that Sharryn’s family 
were chatting among each other telling anec-
dotes and sharing Pizza, Beer and wine in 
her last minutes. This was as it should have 
been, Sharryn would have loved to partake.  
It was my greatest privilege and honour 
spend Sharryn’s last two days at her side. My 
heart broke for her family, friends and col-
leagues, and for all of us who knew her. As 
we were packing Sharryn’s belongings we 
discovered a signed text in her locker for the 
ward staff. Sharryn had clearly planned to 
give this to them but had not had the chance.  
 
At Sharryn’s funeral many members and 
friends travelled to the most amazing church, 
chosen not for its religious sensitivity but its 
amazing architecture. A long and enjoyable 
reception overlooking the water and with 
wine flowing was a great tribute to Sharryn 
where there were countless stories and 
memories exchanged. Sharryn would have 
been with us in spirit and looking down from 
above. We have lost an amazing lady and it 
was a privilege to know her and count her as 
my friend. 
                    Lyn 
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The Louie Blundell Prize 
 
This prize is in honour of our col-
league Louie Blundell and will be 
awarded for the best neuroscience 
nursing paper by a student submitted to the    
Australasian Neuroscience Nurses Association 
(ANNA) for inclusion in the Australasian Journal 
of Neuroscience by the designated date each 
year. The monetary value of the prize is 
AUD$500.  
 
Louie Blundell, was born in England, and alt-
hough she wanted to be a nurse she had to wait 
until after World War II to start her training as a 
mature student in her late twenties. Later she 
and her family moved to Western Australia in 
1959. She worked for a General Practice surgery 
in Perth until a move to the Eastern Goldfields in 
1963.  Subsequently, she worked at Southern 
Cross Hospital and then Meriden Hospital. Dur-
ing this time she undertook post basic education 
to maintain her currency of knowledge and prac-
tice, especially in coronary care.  
 
Louie was also active in the community. She 
joined the Country Women’s Association and 
over the years held branch, division and state 
executive positions until shortly before her death 
in 2007. She was especially involved in support-
ing the welfare of students at secondary school, 
serving on a high school hostel board for some 
time.  
 
She felt strongly that education was important for 
women and was a strong supporter and advo-
cate of the move of nursing education to the ter-
tiary sector, of post graduate study in nursing 
and the development of nursing scholarship and 
research, strongly defending this view to others 
over the years.    
 
For further details and criteria guidelines please 
visit the ANNA website at www.anna.asn.au 
 
  
 
 
 
 
Post Scholarship Requirements 
Successful applicants presenting an oral 
paper must submit a full written paper  to 
be published in the Australasian Journal of 
Neuroscience as part of their award      
requirements before the end of the next 
financial year . The successful applicants 
name will be forwarded to the Journal   
Editor for follow-up.  
2020:  
• Stroke Society of 
Australasia, 30th Anniversary 
Conference, 8th—11 
September, Postponed 
• Neurosurgical Society of 
Australasia, Annual Scientific 
Meeting, 22nd—24th 
September, Sheraton Grand 
Mirage Resort, Port Douglas 
Queensland 
• ANNA Annual Conference, 
11th—13th November, venue 
TBA. https://www.anna.asn.au/     
 
 
 
 
       
2021:  
• Sydney Neuroscience 
Symposium 12th February, 
Royal North Shore Hospital, 
Sydney Australia. 
• WFNN Congress                         
20-23rd July, Darwin Australia. 
www.wfnn.org 
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The Australasian Journal of Neuroscience publishes 
original manuscripts on all aspects of neuroscience 
patient management, including nursing, medical and 
paramedical practice.  
  
Peer Review  __________________________ 
 
All manuscripts are subject to blind review by a       
minimum of two reviewers. Following editorial revision, 
the order of publications is at the discretion of the    
Editor. 
 
Submission_________________________________ 
 
A letter of submission must accompany each manu-
script stating that the material has not been previously 
published, nor simultaneously submitted to another 
publication. The letter of submission must be signed by 
all authors. By submitting a manuscript the authors 
agree to transfer copyright to the Australasian Journal 
of Neuroscience. A statement on the  ethical aspects of 
any research must be included where relevant and the 
Editorial Board reserves the right to judge the appropri-
ateness of such studies. All accepted manuscripts be-
come copyright of the Australasian Journal of Neuro-
science unless otherwise specifically agreed prior to 
publication.   
 
Manuscripts_________________________________ 
 
Manuscripts should be typed using 10 font Arial in MS 
Word format. It should be double-spaced with 2cm 
margins. Number all pages. Manuscripts should be 
emailed to the AJON Editor at: editor@anna.asn.au  
 
TITLE PAGE:  Should include the title of the article; 
details of all authors: first name, middle initial, last 
name, qualifications, position, title, department name, 
institution: name, address, telephone numbers of    
corresponding author; and sources of support (e.g. 
funding, equipment supplied etc.). 
 
ABSTRACT:  The abstract should be no longer than 
250 words. 
 
KEY WORDS:  3 to 6 key words or short phrases 
should be provided, below the abstract, that will assist 
in indexing the paper.   
 
TEXT:  Use of headings within the text may enhance 
the readability of the text. Abbreviations are only to be 
used after the term has been used in full with the    
abbreviation in parentheses. Generic names of drugs 
are to be used.   
 
REFERENCES:  In the text, references should be cited 
using the APA 6th edition referencing style. The refer-
ence list, which appears at the end of the manuscript, 
should list alphabetically all authors. References 
should be quoted in full or by use of abbreviations con-
forming to Index Medicus or Cumulative Index to Nurs-
ing and Allied Health Literature.  The sequence for a 
standard journal article is: author(s), year, title, journal, 
volume, number, first and last page numbers.   
 
Please see the ANNA we page and or APA style 
guides for further guidance  
 
 
ILLUSTRATIONS:  Digital art should be created/
scanned, saved and submitted as a TIFF, EPS or PPT 
file. Figures and tables must be consecutively num-
bered and have a brief descriptor. Photographs must 
be of a high quality and suitable for reproduction.     
Authors are responsible for the cost of colour illustra-
tions. Written permission must be obtained from sub-
jects in identifiable photographs of patients (submit 
copy with manuscript). If illustrations are used, please 
reference the source for copyright purposes. 
 
Proof Correction_____________________________ 
 
Final proof corrections are the responsibility of the  
author(s) if requested by the Editor. Prompt return of 
proofs is essential.  Galley proofs and page proofs are 
not routinely supplied to authors unless prior           
arrangement has been made with the Editor. 
 
Discussion of Published Manuscripts___________ 
 
Questions, comments or criticisms concerning        
published papers may be sent to the Editor, who will 
forward same to authors. Reader’s letters, together 
with author’s responses, may subsequently be        
published in the Journal. 
 
Checklist___________________________________ 
 
Letter of submission; all text 10 font Arial typed double-
spaced with 2cm margins; manuscript with title page, 
author(s) details, abstract, key words, text pages,    
references; illustrations (numbered and with captions); 
permission for the use of unpublished material, email 
manuscript to editor@anna.asn.au 
 
Disclaimer__________________________________ 
 
Statements and opinions expressed in the Australasian 
Journal of Neuroscience are those of the authors or 
advertisers and the editors and publisher can disclaim 
any responsibility for such material. 
 
Indexed____________________________________ 
 
The Australasian Journal of Neuroscience is indexed in 
the Australasian Medical Index and the Cumulative 
Index of Nursing and Allied Health Literature CINHAL/
EBSCO.  
 
 
Don’t forget to join us on Facebook 
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